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Abstract 
 Participation of metabolism in stem cell differentiation has been largely 
disregarded until recently. Here, functional proteomics and metabolomics were performed 
to unveil the mitochondrial and nuclear metabolism during dimethyl sulfoxide (DMSO)-
induced differentiation of P19 cells. DMSO-treated cells were shown to exhibit increased 
glycolytic enzymes activities and fuel pyruvate into oxidative phosphorylation. 
Subsequently, enzymes of electron transport chain also had elevated activities upon 
differentiation. These changes in mitochondrial metabolism were concomitant with 
increased mitochondrial biogenesis as PGC-1α expression was higher in the differentiated 
cells. To study nuclear metabolism, particular focus was placed on delineating a potential 
role of nuclear lactate dehydrogenase (LDH). Nuclear LDH was found to exhibit higher 
expression in pluripotent cells. NAD
+
 generated from LDH reaction was discovered to 
promote histone deacetylation via sirtuin-1 (SIRT1). Drastic alterations in mitochondrial 
and nuclear metabolism during differentiation point to a pivotal role of metabolism in 
deciding the final destination of stem cells.  
 
 
 
 
 
 
 
Keywords: Stem cells, differentiation, mitochondrial metabolism, nuclear metabolism, 
mitochondrial biogenesis. 
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1. Introduction 
1.1 Cellular metabolism 
1.1.1 Metabolism 
Metabolism involves the various essential biochemical reactions within the cells 
of viable organisms. It facilitates life by providing the necessary substituents required for 
growth, energy production, cellular communication and damage repair. These metabolic 
networks are mediated and interconnected by numerous enzymatic reactions making 
metabolism one of the most complex cellular processes [1]. The dynamics of metabolism 
is derived from these highly sophisticated connections among the biochemical reactions. 
Each reaction, however, plays a unique role in the system.  
1.1.1.1Roles of metabolism 
The role of metabolism can be divided into four categories. Anabolism constructs 
molecules from smaller units. Catabolism breaks down larger organic molecules into 
smaller units. Energy production generates the necessary energy currency required to 
facilitate cellular functions. Lastly, metabolism is also involved in signaling processes 
(Figure 1.1).  
Carbohydrate, amino acid, nucleic acid and lipid anabolism are the major form of 
anabolism in cellular processes. Carbohydrate anabolism helps synthesize simple 
monosaccharides from organic acids, fatty acids from sugar and store energy reserves in 
form of glycogen and other molecules. Amino acid anabolism promotes production of 12 
non-essential amino acids in humans, participates in the disposal of intercellular 
nitrogenous wastes and protein biosynthesis. Nucleotides are synthesized through 
purine/pyrimidine metabolism and become four nucleic acids. Lipid anabolism 
contributes in the formation of complex lipids such as steroids and sphingolipids. 
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Figure 1. 1. Basic functions of metabolism 
The function of metabolism is divided into catabolism, anabolism and energy production. 
Catabolism promotes breakdown of macromolecules. Anabolism synthesizes 
biomolecules such as glycogen, protein and nucleic acids. Energy metabolism provides 
the energy to operate cellular functions. 
 
Catabolism promotes breakage of larger molecules into small molecules. These 
smaller molecules can be utilized in anabolic processes. For instance, fatty acids and 
glycerol can be broken down into acetyl-CoA, which can then be oxidized in the 
tricarboxylic acid (TCA) cycle and the electron transport chain (ETC) to generate ATP. 
Energy is essential for any living organism to maintain proper function. The 
energy metabolic pathways, however, vary among the organisms as their source of energy 
differs. Chemoorganoheterotrophic organisms are often a focus in metabolic studies as it 
governs energy production in human. Once the complex carbohydrates are broken down 
into acetyl-CoA via processes such as glycolysis and β-oxidation of lipids (break down of 
complex lipid molecules), it can then enter the TCA cycle to undergo decarboxylation and 
produces NADH and FADH2. The production of NADH and FADH2 is facilitated by 
numerous dehydrogenases which assist in transferring high energy electrons to reduce 
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NAD
+
 and FAD
2+
. Subsequently, NADH and FADH2 molecules transfer their electrons to 
Complex I and Complex II, respectively. ETC then relays the electrons to create ATP via 
ATP synthase [2]. 
More recently the role of metabolism in cellular signaling has begun to emerge. 
The plasticity of metabolic networks permit a cell to communicate information through 
appropriate metabolites generated or consumed. Mailloux et al (2007) have demonstrated 
that metabolism is used to pool specific metabolites in order to remove or remedy the 
effect caused by stressors [3]. AMP has also been found to be closely related to 
maintaining energy status of the cells via various mechanisms [4]. Metabolic feedback is 
another example where metabolism is used to coordinate the activities of a cell to sustain 
efficiency.  
 
1.1.2 Metabolic regulation 
 Metabolic regulation helps control the direction of the metabolic reaction. 
Absence of regulation may promote production of undesired substrates. Thus, it is 
imperative that cells must strictly maintain metabolic regulations to ensure the synthesis 
of required products. Metabolic homeostasis is achieved via a series of mechanisms that 
control the direction of metabolites in response to the requirement of the organism. The 
metabolic network can be regulated by transcriptional regulations, posttranslational 
modifications and metabolic feedback mechanisms. These mechanisms can both act in an 
individual manner or operate in tandem (Figure 1.2). 
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Figure 1. 2. Three major forms of metabolic regulation 
The metabolism is regulated primarily by three forms: 1) transcriptional, 2) post-
translational modification, and 3) metabolic feedback mechanisms. Transcriptional 
factors affect actual gene expression and modify transcription-linked gene expression. 
Post-translational modification is performed by changing the chemical composition of a 
protein via acetylation, phosphorylation, methylation, etc. Metabolic feedback 
mechanisms utilize substrates and products to either inhibit or enhance enzymatic 
activities. 
 
1.1.2.1 Transcriptional regulation 
Transcriptional regulations are crucial in maintaining the efficiency and 
organization of the metabolic network. These regulatory mechanisms involve 
transcription factors that directly interact with DNA to promote changes in gene 
expression and transcriptional coregulators or coactivators [5]. In recent years, there have 
been increased efforts in studying the cofactors of transcriptional regulation as they 
participate in fine-tuning of the transcriptional response. Cofactors such as PPAR gamma 
coactivator 1α (PGC-1α), steroid receptor coactivator 1 (SRC-1), and transcriptional 
intermediary factor 2 (TIF2) have provided clear evidence that genetic regulation 
maintains cellular metabolism [5]. 
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PGC-1α is a master regulator of mitochondrial biogenesis and energy expenditure 
[6]. This particular coregulator has been related to various metabolic functions. In brown 
adipose tissue, PGC-1α acts as a protein that controls adaptive thermogenesis. Upon 
fasting, hepatic cells increase PGC-1α expression to promote gluconeogenesis. In skeletal 
and cardiac muscle, PGC-1α promotes mitochondrial biogenesis and respiration. Thus, it 
is evident that PGC-1α expression reflects the energy status and the energy needs of a cell. 
Transcription factors that are influenced by PGC-1α include PPARγ, PPARα, ERRα, 
FOXO1, HNF4α and NRF1 [7,8,9,10,11]. These pathways ultimately modulate the 
activity of metabolic pathways such as gluconeogenesis, fatty acid synthesis and 
oxidation and glycolysis. 
 
1.1.2.2 Posttranslational modification 
Post-translational modification (PTM) mechanisms involve altering the original 
chemical composition of a protein [12]. This process is commonly done by covalent 
addition of a small molecule to amino acid residues via specialized proteins [13]. 
Phosphorylation, acetylation, methylation, glycosylation, lipidation, flavinylation, 
ubiquitylation and proteolysis are common forms of PTM in eukaryotes [14]. Protein 
phosphorylation is, however, the most frequent and well studied.  There are more than 
2300 phosphoproteins in Saccharomyces cerevisiae and their production and activation 
are governed by a wide array of kinases and phosphatases [13]. The importance of 
phosphorylation is evident from many studies. In the yeast, 23 of 924 metabolic enzymes 
are known to be regulated by PTM via phosphorylation. However, an increasing number 
of studies indicate that there are even more enzymes in metabolic networks that are 
regulated by phosphorylation (Figure 1.3) [15,16,17,18]. More studies are required to 
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further understand the full extent of the influence of PTM on metabolic enzymes and the 
overall metabolic network. 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
 
Figure 1. 3. Metabolic enzymes regulated by post-translational modification (PTM) in 
Saccharomyces cerevisiae. 
 
The enzymes detected or verified to undergo phosphorylation (red), acetylation (blue), 
methylation (grey) and thiolation (green). Functionally verified PTMs are illustrated with 
solid circles. Open circles indicate detected but not yet functionally validated PTMs. 
Refer to [13].  
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1.1.2.3 Metabolic feedback 
Metabolic feedback regulation is a well recognized route of enzyme inhibition, 
especially those in metabolic networks. Feedback mechanisms inhibit or activate 
enzymatic activities by utilizing the downstream product of the biochemical reactions. 
This process prevents overproduction of products. This means of modulating metabolic 
networks is similar to the regulation of cellular signaling, relaying on nodal enzymes or 
substrates to monitor the pathways [19].  
Phosphofructokinase-1 (PFK-1) and pyruvate kinase (PK) are two well known 
examples of metabolic enzymes that are regulated through feedback mechanism. PFK-1 
phosphorylates fructose-6-phosphate to generate fructose-1,6-bisphosphate. 
Phosphorylation of this enzyme is particularly important in regulating glycolysis as it is 
responsible for catalyzing the committed step of glycolysis. Metabolites such as AMP, 
ADP, ATP, fructose-2,6-bisphosphate and citrate are some of the recognized allosteric 
regulators of PFK-1 [20]. Glucose levels are also an important factor in regulating PFK-1. 
Under high glucose conditions, continuous production of fructose-6-phosphate is 
favoured. The fructose-6-phosphate is consumed by phosphofructosekinase-2 to produce 
fructose-2,6-bisphosphate. This metabolite is then used to positively reinforce the activity 
of PFK-1. If glucose levels are low, it leads to lower fructose-6-phosphate levels within 
the cell, subsequently causing the reduced level of fructose-2,6-bisphosphate production. 
Under decreased fructose-2,6-bisphosphate conditions, fructose-1,6-bisphophatase 
(F16BP) remains uninhibited and promotes the reaction in the opposite direction towards 
gluconeogenesis (Figure 1.4a). PK is another enzyme that modulates metabolism via 
allosteric inhibition. ATP is responsible for the inhibition of the enzyme, resulting in the 
accumulation of phosphoenolpyruvate (PEP). PEP causes inhibition of triosephosphate 
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isomerase, stimulating the pentose phosphate pathway and promoting production of 
NADPH, a crucial reducing agent. The production of NADPH makes the pentose 
phosphate pathway an important defense mechanism to counter the effects of reactive 
oxygen species (ROS) or other endogenous and exogenous oxidative stress causing 
agents [21] (Figure 1.4b).  
a)        
         
b) 
 
Figure 1. 4. Modulation of metabolism by feedback mechanism. 
a) Increased cellular respiration promotes ATP and ROS generation. The ATP is used to 
inhibit pyruvate kinase and creates pools of PEP which can inhibit topoisomerase (TPI). 
Inhibition of glycolysis directs metabolites through the pentose phosphate pathway 
increasing production of NADPH, used to counteract the increased ROS. b) PFK-1 and 
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fructose-1,6-bisphosphatase are enzymes that regulate glycolysis and gluconeogenesis, 
respectively. Both enzymes are positively and negatively regulated by the metabolites 
illustrated in the figure. 
 
1.1.3 Metabolic compartmentalization 
Metabolic compartmentation refers to the non-homogenous allocation of 
metabolic pathways and enzymes within the cell. This differential localization of 
metabolism plays a key role in metabolic regulation as it concentrates and separates 
metabolites and enzymes within the organelles [22]. Present understanding of 
compartmentalization is based on the endosymbiotic origin of organelles [22]. Cellular 
compartments include most of the organelles found within the cell such as mitochondria, 
chloroplasts, peroxisomes, glycosome, lysosome, endoplasmic reticulum, nucleus and 
golgi apparatus. However, chloroplasts and mitochondria are the most studied examples 
of metabolic compartments. Chloroplasts were once free-living cyanobacteria that 
transformed into oxygen photosynthetic compartments of the eukaryotic cells [23,24]. 
Mitochondria are also believed to have evolved from proteobacteria to oxygen-dependent 
and oxygen independent pyruvate breakdown compartments of the organism [25,26]. 
Both organelles contain their own unique DNA, which further establishes the possibility 
that these organelles were once free-living organisms. Despite the reduced number of 
genomes in these organelles, chloroplasts and mitochondria can still contain several 
thousand proteins [27].  
The origin of other organelles such as glycosomes and peroxisomes are not 
considered to be endosymbiotic. The unique metabolic pathways of these organelles must 
be transferred into their membrane enclosed compartments created by the endoplasmic 
reticulum. It would be highly burdensome to the cells to redirect individual enzymes one 
11 
 
at a time to the designated compartment. Thus, the whole metabolic pathway is suggested 
to be transferred. This transfer of entire metabolic pathways is theorized to originate 
during evolution and natural selection and may be derived from mistargeting of the 
proteins. It is clear that 100 percent protein targeting is not a realistic estimate. A small 
portion of enzymes will potentially end up in other organelles. Then, the mistargeting for 
all proteins of a pathway to incorrect organelles could also be possible. This would 
provide biochemically functional units and can potentially operate to increase or decrease 
natural selection of these particular changes [22]. 
The metabolic compartmentalization in eukaryotes plays a key role in metabolic 
homeostasis. Chemicals and enzymes in freely diffused form in cytoplasm would prove to 
be extremely inefficient as the right substrate-enzyme interaction would be left to chance. 
By providing a site and clustering of metabolites and enzymes, cells can maintain their 
metabolic efficiency [28]. 
 
1.1.3.1 Cytosolic metabolism 
Cytoplasm, also called cytosol, is a viscous component residing within the cell 
membrane and surrounding the nucleus and the cytoplasmic organelles. Biochemical 
pathways such as glycolysis, pentose phosphate pathway, fatty acid synthesis, amino acid 
metabolism, steroid synthesis, glycogen synthesis and all other networks that are 
associated with these pathways can be found in the cytosolic portion of a eukaryotic cell. 
Glycolysis is one of the key contributors in energy metabolism and it converts 
incoming glucose into pyruvate via a series of enzymatic reactions. Glucose is transported 
into the cell via glucose transport proteins (GLUT). The initial reaction of the glycolytic 
pathway is performed by hexokinase (HK), catalyzing the first committed step of glucose 
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metabolism by phosphorylating glucose and producing glucose 6-phosphate (G6P). By 
modifying the entering glucose, this crucial step maintains glucose concentration 
gradients and facilitates continuous glucose influx into the cell [29]. A subsequent 
reaction involves rearrangement of G6P into fructose 6-phosphate by glucose phosphate 
isomerase (GPI). The next step of the glycolysis involves an addition of another 
phosphate group, donated by ATP, to the F6P, producing fructose 1,6-bisphosphate. This 
rate limiting step of the glycolytic pathway is carried out by PFK-1 [20].  Then the 
fructose bisphosphate aldolase divides F16P into two triose sugars, dihydroxyacetone 
phosphate (DHAP) and glyceraldehydes-3-phosphate (G3P) [30].  Triose phosphate 
isomerase (TPI) is another enzyme that participates in both glycolysis and 
gluconeogenesis, as it provides rapid reaction changing DHAP into G3P. This provides 
additional G3P molecule that can be used in the second half of the glycolysis biochemical 
reactions [31]. A final reaction of glycolysis involves transfer of a phosphate group to 
ADP to generate one ATP and pyruvate. The net glycolysis reaction per one molecule of 
glucose yields 2 pyruvate, 2 ATP and 1 NADH. The NADH produced must be 
transported into mitochondria for subsequent biochemical reactions. This is done by the 
malate-aspartate and glycerol-3-phosphate shuttle (Figure 1.5). 
Gluconeogenesis is considered the reverse of glycolysis. However, several 
enzymes involved in this metabolic pathway differ from that of glycolysis. Two key 
enzymes are pyruvate carboxylase (PC) and PEP carboxykinase (PEPCK). Pyruvate is 
carboxylated to form oxaloacetate by PC in the mitochondria. Next, oxaloacetate is 
transported out of the mitochondria into the cytosol and there PEPCK decarboxylates 
oxaloacetate to produce PEP, while hydrolyzing one GTP to GDP. The step converting 
PEP into fructose-1,6-bisphosphaste utilizes identical enzymes as the glycolysis, except in 
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the  reverse reaction. F16BP and PFK-1 are two important rate determining steps of both 
glycolytic and gluconeogenesis pathways. This regulation helps to control the recycling 
process between fructose 6-phosphate and fructose 1,6-bisphosphate and maintains 
glycogenic/glyconeogenic flux in the cell [32]. Fructose-6-phosphate is then eventually 
converted into glucose (Figure 1.5). 
The pentose phosphate pathway provides organisms with NADPH and pentose 
sugars. This pathway is considered a major source of NADPH for the cell. NADPH 
provides the reducing equivalent for various biosynthetic reactions and allows 
regeneration of glutathione, a protective mechanism against ROS toxicity. Two main 
pentoses produced from this pathway are ribose 5-phosphate (R5P) and erythrose 4-
phosphate (E4P). R5P is a precursor in the synthesis of nucleotide and nucleic acid and 
E4P is used in aromatic amino acid biogenesis [33,34]. The pentose phosphate pathway is 
divided into two stages; an oxidative phase and a non-oxidative phase (Figure 1.5) [1]. 
Fatty acid synthesis involves the creation of fatty acids from acetyl-CoA and 
malonyl-CoA. This important lipogenesis is performed by acetyl-CoA carboxylase (ACC) 
and fatty acid synthases (FAS). ACC is responsible in converting acetyl-CoA into 
malonyl-CoA for the subsequent FAS reaction. Type I FAS is a multienzyme protein 
found in eukaryotes as the 10 enzymes in the system are covalently linked in 
multifunctional polypeptides. The overall reaction produces a 16-carbon palmitic acid 
from acetyl-CoA and malonyl-CoA. 
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Figure 1. 5. Major cytosolic metabolic pathways. 
Glycolysis is used to metabolize glucose into pyruvate for further energy production via 
oxidative phosphorylation. Glyconeogenesis, on the other hand, uses oxaloacetate derived 
from mitochondria to generate glucose. PFK-1 and F16BP are the only differences 
between the two opposite directed pathway. The pentose phosphate pathway is a pathway 
closely linked to glycolysis. This pathway is regulated by the amount of glucose 6-
phosphate produced from HK. The later metabolite products of pentose phosphate 
pathway can be re-inserted into glycolysis. This illustrates a complex network of 
metabolism as the different pathways share metabolites for different purposes. 
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1.1.3.2 Mitochondrial metabolism 
1.1.3.2.1 Energy metabolism 
Mitochondria, the powerhouse of the cell, contribute in multiple ways in the 
energy status of the cell, mainly through the biochemical pathways such as TCA cycle, 
oxidative phosphorylation, β-oxidation, and initiation of gluconeogenesis. The one 
revolution of TCA cycle requires one acetyl-CoA. This reaction produces three NADH 
and one FADH2, which produces ATP in the electron transport chain. The TCA cycle 
consists of a total of nine biochemical reactions driven by metabolic enzymes. The step 
involving the conversion of pyruvate into acetyl-CoA by pyruvate dehydrogenase (PDH) 
is often considered as the initiation process of the TCA cycle as the enzyme PDH is a key 
modulator of fluxes into the TCA cycle [2]. The second step involves citrate synthase, 
combining the incoming acetyl-CoA with recycled oxaloacetate from the previous TCA 
revolution to form citrate. Then the aconitase catalyzes the interconversion of citrate into 
isocitrate. Aconitase is an enzyme containing an iron-sulfur cluster [4Fe-4S] in its active 
site and because of this particular characteristic, this enzyme has been shown to be 
sensitive to ROS [35] (Figure 1.6). 
Oxidative stress agents such as superoxide can rapidly remove an iron from the 
catalytic site to promote inactivation of the enzyme. Subsequently, this delays the electron 
transfer via the TCA cycle and ultimately ATP production is also affected. This 
mechanism, however, prevents further endogenous ROS production from oxidative 
phosphorylation, thus limiting the additional increase in ROS level. Next, isocitrate is 
oxidatively decarboxylated to produce NADH and α-ketoglutarate by isocitrate 
dehydrogenase (ICDH). There are two isoforms of ICDH in the TCA cycle, NADP
+
-
dependent ICDH and NAD
+
-dependent ICDH. Under normal condition, the NAD
+
-ICDH 
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is predominant in activity. However, in presence of oxidative stress the NADP
+
-ICDH is 
upregulated to produce more NADPH in order to combat the ROS and reduce the level of 
endogenous ROS by limiting NADH production [3]. Figure 1.6 depicts the enzymes 
involved in the TCA cycle and oxidative phosphorylation. 
The NADH and FADH2 produced from the TCA cycle are then subjected to 
oxidative phosphorylation. The ETC couples the energy released in electron transfer to 
ATP production. The regulation of ETC depends on the amount of NADH, FADH2 and 
the availability of ADP to phosphorylate. Complex I, NADH ubiquinone oxidoreductase, 
is responsible for the oxidation of NADH and Complex II, succinate ubiquinone 
reductase oxidizes FADH2. These two initiators of the ETC transfer the electrons to the 
ubiquinone pool. During this process, Complex I also translocates a proton to the inner 
membrane space, while Complex II does not. The electrons in ubiquinol are then 
delivered to the cytochrome c via Complex III, cytochrome bc1. Complex III also 
participates in generating a proton gradient by Q cycle mechanism. The ubiquinol (QH2) 
binds to the Qo site of complex III while ubiquinone (Q) binds to the Qi site of complex 
III. Once bound, QH2 transfers one electron to cytochrome c and the other to Q producing 
a semiquinone radical. This process releases hydrogen into the intermembrane space. The 
semiquinone radical is fully reduced in another cycle to produce QH2. The complete Q 
cycle translocates 4 protons. The electrons transferred to the cytochrome c are delivered 
to the complex IV, cytochrome oxidase, which also pumps protons. Cytochrome c is a 
hemoprotein that can donate electrons on the cytoplasmic side of the mitochondrial inner 
membrane. Once the electrons are donated to the active site containing a heme iron and a 
copper, they are used to reduce molecular oxygen into two water molecules. The protein 
gradient established by the ETC can be used by Complex V, F1F0 ATPase to produce 
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ATP. The F0 domain is a membrane component of the complex V and the F1 domain is a 
matrix component [36]. The F0 region rotates counter-clockwise direction during the 
passage of a proton into the matrix of the mitochondria.  The ADP-bound F1 domain then 
uses the proton motive force to generate ATP with close to 100% efficiency [36] (Figure 
1.6). 
 Another important metabolic role occurring in the mitochondria is β-oxidation. β-
oxidation defines a process in which fatty acids are oxidized to produce energy. This 
phenomenon occurs mainly in heart and skeletal muscles. The fatty acids present in the 
cytosol are transported into the mitochodnria via carnitine palmitoyl transferase (CPT) 
and the acylcarnitine carnitine translocase (ACT). The CPT I is responsible for converting 
CoA into carnitine, then the carnitine acetyltransferase mediates transmembrane exchange 
of fatty acyl-carnitine for carnitine and the ACT catalyzes transfer of carnitine back to 
CoA form. Once in the mitochondria, β-oxidation is initiated by activating the fatty acid 
by forming CoA esters with ATP dependent acyl-CoA synthase. The short-chain and 
medium-chain acyl-CoA synthetases are both found in the matrix of the mitochondria. 
The long-chain acyl-CoA synthetases are found in the outer membrane, extending its 
CoA-binding domain into the cytosol. The activated fatty acids are metabolized first by 
acyl-CoA dehydrogenase, producing 2-enoyl-CoA and reducing FAD in the process. 
Then, the 2-enoyl-CoA hydratase catalyzes the hydration reaction to produce 3-
hydroxyacyl-CoA. The next step involves dehydrogenation performed by 3-hydroxyacyl-
CoA dehydrogenase yielding 3-oxalyl-CoA and NADH. Thiolytic cleavage serves as a 
last step to produce acetyl-CoA, which can be used by the TCA cycle, and shortened fatty 
acid intermediate, which can again undergo additional β-oxidation [37] (Figure 1.6).  
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 Mitochondria are also an initial activation site of gluconeogenesis. Upon the 
activation signal caused by decreased glucose level, pyruvate is carboxylated by PC to 
produce oxaloacetate. Oxaloacetate is then transported out of the mitochondria by a 
malate-aspartate shuttle. Oxaloacetate is first converted into malate by MDH, and malate 
is converted back into oxaloacetate in the cytoplasm. Once the oxaloacetate arrives, 
gluconeogenesis can continue as PEPCK can convert oxaloacetate into PEP. 
  
 
Figure 1. 6. Mitochondrial metabolic pathways. 
Once pyruvate enters into mitochondria and is converted into acetyl-CoA, the TCA cycle 
is initiated for oxidative metabolism. The NADH generated from the TCA cycle can enter 
the electron transport chain to produce ATP. The β-oxidation is another major 
mitochondrial metabolism. The pathway is responsible for breaking down fatty acid into 
acetyl-CoA units, which can be funnelled into TCA cycle. The first step of 
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gluconeogenesis occurs in the mitochondria as malate dehydrogenase transports 
oxaloacetate out to the cytoplasm. 
 
1.1.3.2.2 Other roles of mitochondria 
Mitochondria have been considered to play a critical role in the life of a 
eukaryotic organism as it provides energy-yielding reactions to support all necessary 
cellular functions. The importance of mitochondrial metabolism is indeed evident from 
studies indicating the fatality resulting from interruption of this particular function of 
mitochondria. Recent studies, however, have begun to unravel various other roles of 
mitochondria. In particular, participation of mitochondria in signaling pathways gained 
substantial interests. Apoptosis, a programmed cell death, is one of the better understood 
models of mitochondria related signaling pathway. The effect of cytochrome c and 
apoptosis-inducing factor (AIF) release from mitochondria are prime examples 
demonstrating the participation of mitochondria during apoptosis. Release of cytochrome 
c is shown to initiate caspase activation. Once released to the cytosol, cytochrome c binds 
to Apaf-1, a cytosolic protein containing a caspase-recruitment domain (CARD). This 
causes a structural alteration that leads to oligomerization of the APAF-1 to form the 
apoptosome. The CARD domain of Apaf-1 is exposed to the cytosolic side and the 
multiple procaspase-9 are recruited and autoactivated. The AIF, a flavoprotein that 
resides in the mitochondrial intermembrane space, is released upon induction of apoptosis. 
The AIF is known to be translocated to the nucleus and causes chromatin condensation 
and large-scale DNA fragmentation [38] (Figure 1.7). 
Calcium accumulation has long been established as a function of mitochondria. 
The functional significance, however, was unclear until recently. Mitochondrial calcium 
uptake serves several roles:  it regulates membrane potential, acts as a spatial calcium ion 
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buffer by regulating the local calcium concentration and participates in apoptosis [39] 
(Figure 1.7).  
 
 
Figure 1. 7. Multiple cellular functions of mitochondria 
Mitochondria serve multiple roles in the cell. Most well-known roles consist of energy 
metabolism and β-oxidation. However, studies reveal mitochondria also participate in 
apoptosis, signaling pathways and regulate intracellular calcium concentration. 
 
1.1.3.3 Additional compartmentalized organelles 
The peroxisome serves multiple roles in eukaryotic systems. As the name suggests, 
this organelle contains enzymes that use molecular oxygen to remove hydrogen from 
specific organic substrates in order to produce hydrogen peroxide [40]. Hydrogen 
peroxide produced from the reaction is used by an enzyme called catalase to oxidize other 
substrates. In liver and kidney cells, this type of oxidative reaction serves an important 
role as it provides a mechanism of detoxification of various toxic molecules entering the 
bloodstream. A major function of the oxidative reaction in peroxisomes involves the 
catabolism of fatty acid molecules, much like the mitochondrial β-oxidation process. The 
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peroxisome, however, is responsible for the breakdown of very long chain fatty acyl-
CoAs (VLCFAs) and branched chain fatty acyl-CoAs as the mitochodnria lacks VLCFA 
synthases. The peroxisomal β-oxidation does not come to completion in the peroxisome, 
instead the shortened acyl-CoAs are exposed to the mitochondria for complete catabolism 
into acetyl-CoAs [41] (Figure 1.8).  
The endoplasmic reticulum (ER) is another cellular compartment that contributes 
to the overall metabolism of the cell and helps to maintain cellular and organismic 
metabolic homeostasis. ER, particularly smooth ER, serves as an intermediary and 
complex lipid metabolic center. Among the lipids, ER plays a pivotal role in controlling 
the cholesterol levels. This organelle is also shown to participate in de novo synthesis of 
triglycerols, cholesterol and phospholipids [42] (Figure 1.8). 
 The compartmentalization of cellular metabolism is undoubtedly beneficial in 
terms of increasing and maintaining the efficiency of the system. However, this 
compartmentation does not strictly refer to complete isolation of each metabolic network 
within the organelle. It is evident that the enzymes that have specific roles in one pathway 
frequently have similar or varying roles in other pathways, and even in different 
compartments. Some of the metabolites also provide a connection between the 
compartments as enzymes often respond to each other via the availability of substrates or 
products and co-factors. Thus, the interplay between enzymes and metabolites play 
important roles in modulating cellular activities (Figure 1.8). 
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Figure 1. 8. Metabolic compartmentalization 
Metabolism is compartmentalized into various sections. Nucleus, cytoplasm, 
mitochondria, peroxisome, lysosome and endoplasmic reticulum are some of the 
important metabolism regulating organelles of the cell. 
 
1.1.4 Nuclear metabolism 
Recent discoveries indicating the participation of metabolic enzymes and 
metabolic cofactors in transcriptional regulation demonstrate the presence of metabolic 
compartments within the nucleus itself. The role of metabolism or metabolic enzymes in 
the nucleus, however, still remains elusive to date. Several enzymes have already been 
identified to reside in the nucleus and partake in the process of transcriptional regulation. 
These enzymes include DNA methyl transferase (DNMTs), ATP-citrate lyase (ACL) and 
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acetyl-CoA synthase (ACS), phosphoglycerate kinase (PGK), glyceraldehydes-3-
phosphate dehydrogenase (G3PDH) and lactate dehydrogenase (LDH). 
 
1.1.4.1 Nuclear enzymes and epigenetics 
Nuclear enzymes are commonly associated with DNA replication and 
transcription. Helicase, ligase, DNA and RNA polymerase are some of the nuclear 
enzymes that participate in this extremely crucial function of the cell. The metabolic 
enzymes, however, found in the nucleus are closely linked to epigenetic regulations. 
Epigenetics is a relatively new branch of genetics, related to changes in gene expression 
that are not dependent on a change in the nucleotide sequence [43]. The understanding of 
epigenetics requires an understanding of chromatin structure. Chromatins are organized in 
repeating structure of nucleosomes, which contain double stranded DNA wrapped around 
an octamer of histones. The histone octamers generally contain two copies of each core 
histones H2A, H2B, H3 and H4, structured in form of H3-H4 tetramer and two H2A-H2B 
dimers. Within the nucleosome, the negatively charged backbone of DNA and the 
hypoacetylated positively charged histones are tightly bound by electrostatic interactions 
(Figure 1.9).  
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Figure 1. 9. Condensation of DNA and the overall structure of histone proteins. 
The positive charge on the histone molecule is attracted to the negatively charged 
phosphate backbone of the DNA. This allows electrostatic interactions between DNA and 
histones. The DNA wraps around the histones forming “beads on a string” form of 
chromatin. DNA is further condensed and eventually becomes chromosomes. The 
histones are octameric proteins, consisting of two of each H2A, H2B, H3 and H4. 
Illustration is modified from [44]. 
 
Epigenetic modification involves alteration in the electrostatic nature of the 
chromatin or the affinity of chromatin-binding proteins. In particular, histones are 
subjected to several covalent modifications including methylation, acetylation, 
phosphorylation, ubiquitylation, sumoylation, succinylation and malonylation [45]. 
Among the list, histone acetylation and methylation are the most studied and best 
understood types of epigenetic modification. Histone methylation controls gene 
expression by covalently adding the methyl groups to the amino acids, most commonly to 
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the lysine resides. The binding of methyl groups can activate transcription by providing 
binding surface for the chromatin modifying enzymes such as histone acetyltransferases, 
histone deacetylases, methylases and ATP-chromatin remodeling enzymes. The silencing 
of gene expression via methylation occurs as lysine methylation blocks binding of 
proteins that interact with unmethylated histones or inhibiting modification of 
neighbouring residues.  
Histone acetylation exerts its effect on the transcriptional regulation by altering 
the charges on the histone lysine residues. Acetylations on the proteins are executed by 
histone acetyltransferase (HATs). HATs are found in both the cytoplasm and nucleus of 
the cell. Cytoplasmic HATs acetylate histones prior to nuclear localization, while the 
nuclear HATs acetylate histones to activate or silence gene expression. The position of 
acetylation is located on the N-terminal lysine ε-amino groups and HATs utilize acetyl-
CoA as a substrate to attach the acetyl group on these sites. All histones, H2A, H2B, H3 
and H4, are shown to be capable of undergoing acetylation. However, modification of H3 
and H4 are much more extensively characterized than H2A and H2B [46]. Some of the 
important sites of acetylation are located at H3 Lys 9 and 14 and H4 Lys 5, 8, 12 and 16 
residues [47]. Once acetyl groups are attached to the lysine residues, the positive charges 
on the histones are removed. Elimination of positive charges decreases the interaction 
between histones and negatively charged phosphate groups of DNA. This process allows 
chromatin structures to adapt more relaxed structures, which is a requirement for greater 
gene transcription activity. Deacetylation of histones can be achieved by histone 
deacetylases (HDACs). HDACs restore the positive charges on histones by removing the 
acetyl group and ultimately allowing gene silencing by reinstating the interaction between 
histones and DNA (Figure 1.10). There are two protein families that can perform histone 
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deacetylation: SIRT2 family of NAD
+
-dependent HDACs and the classical HDAC family 
[48]. Members of the classical HDAC family are divided further into class I and class II. 
Class I HDACs are found to be expressed in the majority of cell types, however, the class 
II HDACs involvements are suggested to be limited to differentiation and developmental 
processes [48]. As the roles of sirtuins are an important aspect of this study, it will be 
elaborated in detail. 
 
 
Figure 1. 10. Mechanism of histone acetylation. 
Histone acetylation is one of the primary epigenetic modifications that modulate gene 
expression. Histone acetylation and deacetylation both occur on lysine residues of 
histones. HATs are known to be responsible for performing histone acetylation by using a 
acetyl-CoA. This causes the lysine residues to lose the positive charge, in turn 
neutralizing the electrostatic interaction between the DNA and the histone. This allows 
DNA to dissociate and permit transcriptional machinery to access the genes. 
Deacetylation of histone is executed by HDACs. Using NAD
+
 as substrates, HDACs 
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allow the lysine residues regain the positive charge and reforming DNA-histone 
interactions. The acetylation typically promotes increase in gene expressions and the 
deacetylation causes the silencing of the genes.  
 
1.1.4.2 Sirtuins 
Sirtuins are NAD
+
-dependent deacetylases, also called class III HDAC family. 
This recently discovered HDAC family is highly conserved from bacteria to human. In 
mammals, there are seven sirtuins, all containing a conserved NAD
+
-binding and catalytic 
site, making them the only HDAC family that requires the presence of NAD
+
 for their 
enzymatic activity [49] (Figure 1.11). The localization of sirtuins varies; SIRT1,2,6 and 7 
in the nucleus, SIRT1 and 2 in the cytoplasm and SIRT3,4 and 5 in the mitochondria. The 
abundance of sirtuins speaks to its versatility. Sirtuins not only are able to acetylate 
histone but they can also acetylate non-histone protein substrates. The function of 
different Sirtuins also vary: SIRT1 and SIRT5 act as deacetylases, SIRT4 acts as a mono-
ADP-ribosyl transferase, SIRT2, 3 and 6 can perform both deacetylase and mono-ADP-
ribosyl transferase activity and the function of last sirtuin, SIRT7, has not been fully 
delineated to date [50]. Although the mechanism of action remains not fully understood, 
sirtuin-driven deacetylation generally consists of two steps. First, sirtuins cleave NAD
+
 
and produce nicotinamide (NAM) and in the second step the acetyl group is transferred 
from the lysine residue to the ADP-ribose moiety of NAD
+
 to generate O-acetyl-ADP 
ribose. 
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Figure 1. 11. Mechanism of sirtuin NAD
+
-dependent histone deacetylation. 
Sirtuin utilizes NAD
+
 to perform deacetylation of lysine residues on proteins. The 
nicotinamide group from NAD
+
 is replaced with acetyl group and the lysine residues 
deacetylated [49]. 
 
 SIRT1 is the best characterized among the family member and although it resides 
in the nucleus it can be transported to the cytosol. SIRT1 activity is generally linked to 
the metabolic status of the cell. For instance, an increase in SIRT1 activity was displayed 
under energy and nutrient stress [50]. In the nucleus, SIRT1 deacetylation targets are key 
metabolic regulators, enhancing the suggestion that SIRT1 participates in metabolic 
transcriptional regulation. Some of the SIRT1 metabolic targets include p53 
(mitochondrial activation), FOXOs (lipid metabolism and stress resistance), PGC-1α 
(mitochondrial biogenesis and lipid metabolism), PPARγ (adipocyte differentiation, lipid 
synthesis and lipid storage), LXRs (lipid anabolism and cholesterol regulation) and CREB 
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(gluconeogenesis) [50]. However, SIRT1 is also capable of exerting its effect on 
inflammatory response, cell proliferation, apoptosis and cancer [49].  
 SIRT2 is predominantly found in cytosol. It can, however, be transported into the 
nucleus in a cell cycle-dependent manner. SIRT2 migrates to the nuclei during the G2/M 
phase of the cell cycle, deacetylating histone H4 Lys16. This process modulates 
chromatin condensation during metaphase [51]. In addition, SIRT2 expression levels vary 
depending on the cell cycle phase and are commonly increased during mitosis. SIRT2 is 
also found to be responsible in deacetylation of α-tubulin, a major component of 
microtubules [52]. Thus, these observations implicate SIRT2 to be an important regulator 
of the cell cycle.  
 SIRT3 is preferentially localized in the mitochondria and accountable for targeting 
enzymes involved in energy metabolism process, including the ETC, TCA cycle, β-
oxidation and ketogenesis [53]. Through modulating the metabolic enzymes in 
mitochondria, SIRT3 controls the flow of the oxidative pathways and regulates the rate of 
ROS production. Mitochondrial enzymes such as ACS, isocitrate dehydrogenase-2 and 
glutamate dehydrogenase has been identified to be a target of deacetylation by SIRT3 
[54,55,56,57]. SIRT3 also plays a role in other metabolic processes such as acetate 
metabolism and brown adipose tissue thermogenesis [58]. In addition, genetic evidence 
and several mutation studies demonstrate the participation of SIRT3 in longevity [59]. 
 SIRT4 is suggested to be a mitochondrial protein as SIRT4-GFP localized 
specifically to the mitochondria [60]. Although the SIRT4 consists of the NAD
+
-binding 
sirtuin domain, it does not perform deacetylase activity [61].The mono-ADP-
ribosytransferase activity is seldom found in all sirtuin family members and SIRT4 
transfers ADP-ribosyl group from NAD
+
 to histones. This PTM involves N- or S-
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glycosidic linkage between an amino acid arginine or cysteine and ADP-ribose derived 
from NAD
+
. The enzyme glutamate dehydrogenase (GDH) was the first mitochondrial 
protein to be discovered as being inactivated through SIRT4 mono-ADP-ribosylation [61]. 
SIRT4 has been linked to insulin secretion in pancreatic β cells. By inactivating GDH in 
the β cell mitochondria, SIRT4 limits the conversion of glutamine and glutamate into α-
ketoglutarate [61]. Subsequently, this limits the production of ATP and hinders the amino 
acid-stimulated insulin secretion pathway. 
 SIRT5 is another mitochondrial residing protein. SIRT5, however, is localized in 
the matrix of the mitochondria. It was first discovered to deacetylate cytochrome c in the 
intermembrane space of mitochondria [56]. However, it is still unclear with regards to the 
mechanism of translocation of SIRT5 into the mitochondrial matrix. The confirmed 
substrate of SIRT5 thus far includes carbamoyl phosphate synthetase-1 (CPS1), the rate-
limiting enzyme in the urea cycle [62]. The deacetylation activates CPS1 and it leads to 
overall up-regulation of ammonia detoxification. It has been shown experimentally that 
SIRT5 knock-out mice have elevated ammonia levels during starvation or on a high-
protein diet [63].  
 SIRT6 is localized in the nucleus and is responsible in deacetylation of histone H3 
Lys 9 and H3 Lys56. SIRT6 is specific in its substrate, as it displays low deacetylation for 
any other histones. In particular, H3 Lys56 deactylation has been associated with genomic 
stability and DNA damage sensitivity in eukaryotes [64]. The roles of SIRT6 have been 
suggested to be related to regulating telomeric chromatin, gene expression and the 
chromatin association of DNA repair factors. The deacetylation sites of SIRT6 are likely 
providing a change in chromatin structure at DNA double strand break locations for 
efficient association of repair proteins. The deacetylation at this site has also been linked 
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to transcriptional repression of nuclear factor-kappa B (NF-κB), a transcription factor in 
regulating aging, proliferation and inflammation gene expressions [65]. In addition, 
SIRT6 has been linked to metabolism by associating with HIF-1α. 
 SIRT7 is one of the least understood proteins of all other sirtuins. SIRT7 is 
proposed to be localized mainly in the nucleolus, where it participates in the regulation of 
ribosomal RNA (rRNA) transcription by controlling the activation of RNA polymerase I 
[65]. This activity of SIRT7 is particularly relevant in reactivation of rDNA transcription 
at the end of mitosis. The exact mechanism of how this protein operates, however, is still 
unknown. A recent study recognized a crucial role for SIRT7 in phenotype and 
transformation of cancer cells. It was found that SIRT7 specifically targets H3 Lys18 for 
deacetylation. This site is mainly found around the transcription start site of nuclear 
hormone receptors and hypoacetylation of H3 Lys18 site and it has been associated as a 
marker for malignancy in various human cancers [66]. 
The uniqueness of the sirtuin family arises from the fact that the activity of these 
proteins are directly related to the NAD
+
:NADH ratio in the cell. The level of NAD
+
 in 
the nucleus has been implicated to be the primary effector of the sirtuin-mediated 
silencing [67,68]. Thus, the biosynthetic and breakdown products of the NAD
+
 in the 
cells play a crucial role regulating the activity of sirtuins. There are two main routes of 
NAD
+
 biosynthesis in mammals: a de novo kynurenine pathway and a salvage pathway 
[69,70]. The kynurenine pathway involves degradation of tryptophan into NAD
+
, while 
the salvage pathway utilizes nicotinic acid, nicotinamide and nicotinamide riboside. 
NAD
+
:NADH ratio within the cells can also be modulated and influenced by the 
metabolic network itself. Thus, sirtuins are suggested to be directly linked to the cellular 
metabolic states and participate in orchestrating complex cellular processes such as 
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energy metabolism. Aforementioned, metabolic enzymes are often regulated by means of 
post-translational modification. Thus, many enzymatic activities in glycolysis, 
gluconeogenesis, TCA cycle, fatty acid metabolism and glycogen metabolism are 
modulated by acetylation. Sirtuin family members have been suggested to participate in 
an adjustment between storage and utilization of energy by direct deacetylation of 
metabolic enzymes. Deacetylation of the glycolytic, TCA cycle and fatty acid oxidation 
enzymes was linked to negative regulation. Gluconeogenesis enzymes, however, 
experienced positive regulation upon deacetylation (Figure 1.12).  
 
 
Figure 1. 12. Types and roles of Sirtuins. 
Sirtuins are found throughout cellular compartments. There are a total of seven identified 
sirtuin family members that possess either deacetylase activity (SIRT 1, 2, 3, 5, 6) or 
mono ADP ribosyl transferase activity (SIRT 2, 3, 4,6). However, the activities of these 
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proteins are not limited to one or the other. The sirtuins are localized in the nucleus (SIRT 
1,6,7), mitochondria (SIRT 3, 5, 6) and cytosol (SIRT 1, 2). As all the sirtuins use NAD
+
 
as a substrate, the level of NAD
+
, which defines the cellular metabolic status, is 
responsible regulating sirtuin activity [71]. 
 
1.1.4.3 Metabolic cofactors 
Any enzymes, especially metabolic enzymes, require the presence of necessary 
metabolites to execute biochemical reactions. This is no exception for enzymes found in 
the nucleus. These metabolites include NAD
+
, AMP, acetyl-CoA, succinyl-CoA, 
malonyl-CoA, pyruvate and many more [72] (Figure 1.13). These metabolites help to 
regulate cellular events in the nucleus through epigenetics. Recent studies have begun to 
recognize the importance of the roles of nuclear enzymes in regulating the concentration 
of key epigenetic substrates. Enzymes such as sirtuin and HATs are some of the well-
known proteins that require the common metabolites such as NAD
+
 and acetyl-CoA, 
respectively. It is especially important to recognize that these enzymes are responsive to 
metabolic cues as they require metabolites generated or utilized by the metabolic enzymes. 
For histone acetylation, HATs have already been demonstrated to be associated with ACS, 
an enzyme which is responsible for generating acetyl-CoA from acetate. In mammals, 
however, acetate metabolism is not considered to be a major bioenergetic substrate. Thus, 
glucose metabolism related ACL has been suggested to be the regulator of acetyl-CoA 
concentration in the nucleus for the activity of HATs [73].  
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Figure 1. 13. Connection between  cellular metabolism and gene transcription. 
As the metabolic cofactors are common signatures of cellular metabolism, numerous 
metabolic cofactors are involved in modulating cellular metabolism via the regulation of 
transcription. The cofactors found in mitochondria and cytosol can enter the nucleus and 
induce changes in gene transcription level [72].  
 
1.1.4.4 ATP-citrate lyase 
The nuclear localization of an enzyme ACL has been illustrated recently [73]. 
This study bridged the gap between the epigenetic and metabolic enzymes by 
demonstrating that ACL is responsible for providing acetyl-CoA for HATs and affecting 
the expression of glycolytic enzymes through epigenetic modification. Silencing ACL 
expression in the cell significantly reduced the level of histone acetylation as HATs do 
not have acetyl-CoA, a substrate necessary to acetylate histones. Interestingly, Glut4 
expression, an insulin-responsive glucose transporter and three key glycolytic enzymes 
hexokinase 2, PFK-1 and lactate dehydrogenase A (LDH-A) were all shown to be 
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suppressed under ACL silencing. Recovery by acetate was able to rescue these activities. 
Thus, this study demonstrated that ACL plays a crucial role in regulating the level of 
histone acetylation and contributes to the selective regulation of genes involves in glucose 
metabolism. In addition, the link between histone acetylation in adipocyte differentiation 
and ACL has been clarified. Adipocyte differentiation has been demonstrated to involve 
increased histone acetylation. Silencing ACL expression during the differentiation indeed 
caused the amount of histone acetylation to be significantly reduced, along with the 
inability of adipocytes to accumulate lipids (Figure 1.14). This research demonstrated 
how cellular metabolites can directly influence the metabolic compartments. The more 
citrate is available, ACL will up-regulate the glucose metabolizing enzymes via histone 
acetylation to generate more citrate. In turn, this produces a positive feedback loop to 
reinforce the expression of more glucose metabolizing enzymes via ACL-directed histone 
acetylation. Lower glucose conditions will produce opposite effects as citrate levels will 
also be diminished. 
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Figure 1. 14. ACL induced histone deacetylation modulates central metabolism. 
Nuclear ATP-citrate lyase (nACL) was found to be responsible in creating acetate from 
citrate. The citrate level of the cell is shown to regulate the activity of nACL and directly 
influencing the activities of HATs, which regulate histone acetylation. The increase in 
histone acetylation caused by an increase in ACL activity induces increased expression of 
GLUT4, PK, PFK1 and LDHA, thus linking central metabolism to gene expression. 
 
1.1.4.5 Lactate dehydrogenase 
LDH is an enzyme that is responsible for the interconversion of pyruvate and 
lactate. There are five isoenzymes of LDH currently known: LDH-1, LDH-2, LDH-3, 
LDH-4 and LDH-5. Each isoenzyme is tetramer, constructed of four polypeptide chains. 
The subunits are made of two parent chains called LDH A (also called muscle (M) 
subunit) and LDH B (also called heart (H) subunit). The combination of the two subunits 
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form different isoenzymes of LDH. The combinations include BBBB (LDH-1), ABBB 
(LDH-2), AABB (LDH-3), AAAB (LDH-4) and AAAA (LDH-5) [74]. If more A 
subunits present, the enzyme will favour the formation of lactate from pyruvate, along 
with the oxidation of NADH. The A subunits are commonly found to complex with 
NADH, thus facilitating reaction that oxidizes NADH. On the contrary, if more B 
subunits arevpresent, the enzyme will favour the transformation of lactate into pyruvate, 
along with the reduction of NAD
+
. The B subunit of LDH complexes with NAD
+
, thus 
this complex further promotes the conversion of NAD
+
 to NADH and lactate to pyruvate  
[75]. Interestingly, LDH-1 is maximally activated under low pyruvate concentration and 
inhibited by excessive presence of pyruvate but LDH-5 is resistant to the pyruvate 
inhibition. LDH-1 is comprised solely of heart or B subunit and found predominantly in 
heart, where the pyruvate levels do not or should not develop in high abundance as 
pyruvate would readily be oxidized by the mitochondria. Inhibition of LDH-1 by 
pyruvate is logical in attempt to favor oxidative metabolic pathway. Alternatively, LDH-5 
is constructed with only A subunits and found primarily in skeletal muscle. Skeletal 
muscles rely on anaerobic glycolysis for the energy supply. Thus, it would be 
advantageous for skeletal muscle LDH to resist high pyruvate levels and be permitted to 
convert pyruvate into lactate. 
All isoforms of LDH are found in the cell, but their concentration varies from 
tissue to tissue. In cytosol, LDH serves to complete the last step of lactic acid 
fermentation. The reaction involves reduction of pyruvate to lactic acid and providing 
NAD
+
. The purpose of this reaction is to replenish the NAD
+
 level for further glycolytic 
pathways to produce energy. LDH has also been shown in the mitochondria. 
Mitochondrial LDH has been suggested to participate in tissue lactate clearance and 
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oxidation. As glycolysis inevitably produces cytosolic lactate, mitochondrial LDH helps 
to balance the lactate produced from cytoplasm. LDH in mitochondria was also shown to 
generate ATP, maintain lactate homeostasis and modulate redox potential in human 
astrocytic cells [76]. LDH is also found in the nucleus. Phosphorylation at tyrosine 238 
site has been linked to the restriction of LDH in the nucleus in PC12 cells [77]. In 
particular, LDH-5 has been exclusively found in the nucleus and has been previously 
suggested to complex with single-stranded DNA to stimulate DNA polymerase α-primase 
activation [78]. In addition, LDH has been hypothesized to modulate reparative and 
replicative DNA synthesis. Because LDH can enter the nucleus and potentially bind 
cofactors, substrates and inhibitors, this particular enzyme could establish a regulatory 
linkage between the energy states of a cell and the DNA replicative and reparative 
functions [78]. More recently, LDH has been shown to play a role in cancer progression 
by modulating HIF-1α and HIF-2α expression under low oxygen and energy conditions 
[79]. However, a clear role of nuclear LDH still remains elusive to date. 
Recent work from our laboratory discovered that nuclear LDH in HepG2 cells are 
found to be linked to histone acetylation via sirtuin and the production of NAD
+
. The 
sirtuin and nuclear LDH has been demonstrated to be physically linked, suggesting 
formation of multi-protein complexes during ROS stress [80].  
 
1.2 Stem cells 
1.2.1 Stem cells overview 
Stem cells are undifferentiated cells that have the ability to self-replicate and 
transform into any cell type in an organism. Thus, two key prerequisites of stem cells are: 
1) self-renewing ability and 2) plasticity to differentiate into an array of specialized cell 
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types. This process of conversion of stem cells into a committed and more mature 
specialized cell is called “differentiation”. Depending on the source of the stem cells, the 
potential for differentiation and the number of cell types they can transform into also 
varies. There are three categories of stem cells: totipotent stem cells, pluripotent stem 
cells and multipotent stem cells. 
Totipotent stem cells are capable of giving rise to any and all human cells. After 
fertilization, the egg is divided several times to form morula. These cells are considered to 
be totipotent and any individual cell from the morula could in theory give rise to a 
complete human. After several cell divisions, the totipotent cells begin to specialize and 
form the inner cell mass of the blastocysts [81]. The inner cell mass is the source of 
embryonic stem cells, which are pluripotent. Pluripotent stem cells are defined by a stem 
cell that has the potential to differentiate into the three germ layers including endoderm, 
ectoderm and mesoderm, which adds up to 200 different cell types that makes up the 
human body. These pluripotent cells can differentiate into multipotent stem cells. The 
stemness of a multipotent stem cell is limited compared to a pluripotent stem cell, as they 
become more of a specialized progenitor cell. Multipotent cells give rise to cells that have 
a particular function and are commonly recognize to be destined to produce specific types 
of cells or tissues [82] (Figure 1.15). For example, hematopoietic stem cells are destined 
to differentiate into blood cell type cells such as lymphocytes, monocytes, neutrophiles 
and platelets [83], but cannot become non-blood cell types. Hematopoietic stem cells are 
found in the bone marrow of adults and are often used in clinical settings for 
transplantation to regenerate blood-forming components [84]. These progenitor cells are 
commonly characterized as adult or somatic stem cells and are found throughout the 
organism post-development. 
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Figure 1. 15. Stem cell development and three germ layers. 
There are three types of stem cells: totipotent, pluripotent and multipotent stem cells. 
Pluripotent stem cells have the potential to differentiate into three germ layers; mesoderm, 
endoderm and ectoderm. The three layers differentiate into multipotent progenitor cells 
and adult cells. 
 
1.2.2 Development of the embryo and the three germ layer 
To better understand the characteristics of stem cells and the process of 
differentiation, the development of the embryo should be discussed. Once fertilization 
occurs, the zygote starts to divide as it travels to the uterus . The duration of translocation 
is three to four days in mice and five to seven days in humans [81]. The zygote 
synchronously divides into 2 identical cells, 4, 8, 16 cells and so on. The 16-cell embryo 
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is defined as a morula. Compaction occurs and and the cells begin to divide into the  
trophectoderm, (outer rim of cells)  and the inner cell mass. The inner cell mass continues 
to divide and differentiate and give rises to all embryonic tissues. By day 3 of embryonic 
development for mouse and day 5 to 6 for human, the embryo develops a cavity called the 
blastocoele. This cavitation allows a physical separation between the trophectoderm and 
the inner cell mass: the morula thusly becomes a blastocyst [85]. In day 4.5 in mice and 
day 8 to 9 in human, the blastocyst separates into the hypoblast and epiblast. The 
hypoblast give rise to the primitive endoderm and the epiblast, become the only 
pluripotent cells in the blastocyst (Figure 1.16). The epiblast further differentiates into the 
embryonic ectoderm and the primitive ectoderm.. The next major development occurs as 
the embryonic ectoderm becomes the three germ layers – endoderm, mesoderm and 
ectoderm. This phase of the embryonic development is termed gastrulation. The 
endoderm layer develops into the interior epithelial lining of the digestive and respiratory 
system. It also forms the lining of all glands which open into digestive tubes such as liver 
and pancreas. The mesoderm, or middle germ layer, gives rise to tissues and structures 
including bone, cartilage, muscle, connective tissue, blood,  vascular, reproductive 
excretory and urinogenital systems. Lastly, the ectoderm differentiates into the nervous 
system, tooth enamel and the epidermis. It can also differentiate into the lining of the 
mouth, nostril, sweat glands, hair and nails.  
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Figure 1. 16. Embryonic development 
The zygote is formed when the sperm fertilizes the oocyote. The zygote then divides 
continuously through 2 cell, 4 cell, 8 cell and 16 cell stages (morula). Once past the 
morula stage, trophectoderm and inner cell mass (ICM) begin to develop. The embryonic 
stem cells are derived from the ICM [86]. 
 
1.2.3 Types of stem cells 
There are many types of stem cells including early embryonic, blastocyst 
embryonic, fetal, adult, amniotic, cord blood and induced pluripotent stem cells. Adult, 
induced pluripotent and embryonic stem cells are, however, more commonly utilized in 
research. Adult or somatic stem cells are lineage-restricted cells and are found in tissues 
throughout the body. These types of stem cells are responsible for tissue homeostasis and 
regeneration [87]. Somatic stem cells are capable of an extended self-renewal period 
compared to other stem cells, as their continual self-replication is essential in maintaining 
tissue homeostasis. The microenvironment, or niche, which surround adult stem cells 
contain factors that are necessary for the long-term self-renewal of the cell [87]. The 
niche regulates cell to cell interaction between stem cells and neighbouring cells, controls 
oxygen availability, contains hormones, signaling molecules and metabolites to maintain 
the physiochemical status of the environment. Stem cells are localized in a small reservoir 
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and can replenish the tissues as needed when specific environmental cues occur. The hair 
follicle is one of the prime examples demonstrating the regulatory involvement of niches. 
During the degenerative phase of the hair cycle, receding follicles carry the dermal papilla, 
a specialized mesenchymal cell, from the base of the hair bulb up to the bulge. This 
alteration in the microenvironment stimulates progenitor cells to exit the niche and 
proliferate and differentiate [87] (Figure 1.17).  
 
 
Figure 1. 17. Adult stem cells and their niche. 
Hair follicles consist of multipotent stem cells found in the bulge. These adult stem cells 
give rise to transit-amplifying matrix cells, which differentiate into hair shaft and the 
channels that surrounds the shaft. The follicle is surrounded by a basement lamina which 
is surrounded in turn by a dermal sheath. The surrounding microenvironment of the 
follicle is shown to stimulate differentiation of these adult stem cells or allow the stem 
cells to maintain their stemness [87]. 
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Induced pluripotent stem cells (iPSCs) are special stem cells that were first 
engineered by Takahashi and Yamanaka in 2006 [88]. This group was successful in 
reverting differentiated somatic cells back into the pluripotent state by transfecting the 
cells with four “stemness” transcription factors: SOX2, OCT4, KLF4 and c-MYC. 
Studies thus far suggest that iPSCs are similar to the natural embryonic stem cells in 
many aspects such as expression of stemness genes and proteins, embryoid body 
formation, teratoma formation and ability to differentiate, to name a few. However, the 
full extent of the relationship between iPSCs and natural pluripotent cells are still under 
investigation. The discovery of iPSCs is considered to be one of the major breakthroughs 
in stem cell research as these cells could potentially provide a mean of obtaining 
pluripotent cells without creating or destroying embryos [88]. In particular, iPSCs have 
been hypothesized to be a useful asset in clinical settings. As the undifferentiated stem 
cells are obtained from the host differentiated somatic cells, these stem cells are patient- 
and disease-specific [89]. This will allow exploration of in vitro disease modeling, high 
throughput drug discovery and screening and regenerative therapies, reducing possible 
immune-rejection in stem cell therapy [89]. It should, however, be recognized that iPSCs 
are still a recent discovery and further extensive investigation must be done to identify the 
true potential of these unique stem cells. 
 Embryonic stem cells (ESCs) are one of the most studied models in the field. 
ESCs are derived from the inner cell mass of the blastocyst or earlier morula stage 
embryos. These cells maintain their pluripotency and are considered immortal (self-
renewal ability). However, these stem cells do require some extrinsic factors such as 
serum free media supplemented with a specific factor, inactivated embryonic fibroblast 
cells or other types of feeder layers to maintain their stemness [90]. For mouse ESCs, 
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leukemia inhibitory factor (LIF) and the LIF/signal transducer and activator of 
transcription 3 (STAT3) signaling pathway has been illustrated to play a crucial role in 
conserving pluripotent states. The pathway is initiated by binding of LIF to leukemia 
inhibitory factor receptor (LIFR) and acts via gp130 receptors to activate Jak kinases (JK) 
and STAT3 [91]. The STAT3 proteins are then transported into the nucleus to activate the 
transcription of key stemness maintenance genes, c-Myc and Klf4. The interaction 
between LIFR and gp130 also promotes activation of the phosphoinositide 3-kinase 
(PI3K)/ protein kinase B (AKT) signaling pathway and Ras/mitogen-activated protein 
kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway [92,93]. PI3K/AKT 
activates T-box3 and inhibits differentiation by preserving Nanog expression. 
Ras/MAPK/ERK activation leads to regulation of Myc and Elk transcription factors. The 
inhibition of ERK signaling has been shown to promote self-renewal in ESCs [94] 
(Figure 1.18).  
The human ESCs require basic fibroblast growth factor 2 (FGF2) . Activin 
A\TGFβ signaling pathway is also an  important in the self-renewal process of human 
ESCs [95]. Binding of FGF2 to the fibroblast growth factor receptor (FGFR) activates 
PI3K/AKT signaling to promote self-renewal of stem cells, similar to the effect of LIF on 
mouse ESCs. Consequently, this also inhibits BMP initiated signals which also promote 
self-renewal. Currently, there are many different types of ESCs available for research. 
Embryonal carcinoma cells (ECCs) are a variation of “normal” ESCs. ECCs are the 
malignant counterpart of ESCs and are derived from teratocarcinomas, a germ line 
tumour [96]. These teratocarnomas are isolated from malignant tumours in the testis of 
mice and human and contain a population of undifferentiated stem cells. These 
undifferentiated tumour cells are pluripotent and capable of self-renewing, an important 
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characteristic of all stem cells. F9 and P19 cell lines are two mouse ECCs commonly used 
in stem cell research. Although the clinical potential for these cells are limited due to their 
malignant characteristics, these cells are model systems: the cellular and molecular 
aspects of early differentiation are easily studied in these cells lines. The major 
advantages of ECCs are that they are easy to maintain, and to manipulate genetically [96]. 
Differentiation can also be controlled reproducibly with inducers such as All-trans 
retinoic acid (ATRA) and dimethyl sulfoxide (DMSO) [97].  
 
 
Figure 1. 18. Leukemia inducing factor helps to maintain pluripotency. 
Binding of LIF to the LIF receptor (LIFR) promotes phosphorylation of the receptors. 
This recruits JAK1 and STAT3 proteins, activating STAT3 signaling pathway and 
promoting increased gene expression of SOX2 and cMyc. Phosphorylation of LIFR also 
induces PI3K/Akt pathway to initiate and promote enhanced expression of Nanog. 
Increased expression of both Nang and SOX2 promotes a feedback loop and subsequently 
maintains self-renewal and stemness of the stem cells. 
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1.2.4 Maintenance of pluripotency 
The pluripotency of stem cells is shown to be governed by a unique set of 
transcription factors. Maintaining the expression of these factors allows cell to conserve 
their stemness. Many genes are crucial in maintain pluripotency such as Oct4,  Sox2, 
Nanog, Tbx3, Essrb, Tcl1, Rif1, Nac1, Sall4, Dax1 and Zfp281[98]. Oct4, Sox2 and 
Nanog, however, are considered to be the core members among the stemness group 
[99,100]. Oct4 and Nanog share 345 genes in mouse ESCs. In human ESCs, Oct4, Sox2 
and Nanog co-bind 353 target genes,  demonstrating that a substantial fraction of target 
genes are shared among the three crucial factors [101]. The three factors are also in a 
feed-forward self-activating autoregulatory loop, while activating downstream self-
renewal genes and repressing differentiation genes [58]. The autoregulatory loop is 
crucial in preserving the high levels of expression of the key stemness genes and 
preserving pluripotent states of the cell (Figure 1.19). 
 
 
Figure 1. 19. Master regulators of self-renewal Oct4, Sox2 and Nanog. 
The master regulators OCT4, SOX2 and NANOG are positioned inside the dashed circle. 
Presence of master regulators maintain the self-renewal characteristics of stem cells. Note 
that the initiation of pathways requires the expression of the master regulators. [102]. 
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OCT4, also known as OCT3 or OCT3/4, is a Pou5f1 encoded transcription factor. 
OCT4 belongs to Pit-Oct-Unc (POU) transcription factor family. POU family members 
are known to target genes by binding an octameric sequence motif of an AGTCAAAT 
consensus sequence [103]. The POU domain of OCT4 binds DNA. N-terminal domain 
acts as transactivation domain and C-terminal domain acts as  cell specific transactivation 
domain [104].This transcription factor is considered to be a master regulator for the 
initiation and maintenance of pluripotent cells during embryonic development. The 
expression of OCT4 remains high during pluripotent states and it rapidly disappears in 
differentiation. However, the level of Oct4 must also be maintained within a normal range 
to sustain pluripotency [105,106,107]. The expression level of OCT4 has been 
demonstrated to influence the fate of stem cells. For instance, reducing OCT4 expression 
by half promotes ESCs to differentiate into trophoblasts, while less than a twofold 
overexpression induces ESCs to become primitive endoderm and mesoderm [58].  
SOX2 works concomitant with OCT4 to control pluripotency and it is also 
considered a master stemness gene [108]. SOX2 can heterodimerize with OCT4 to co-
occupy HMG and POU motifs on regulatory DNA sequences [109]. Like OCT4, the 
expression of level of SOX2 is also tightly controlled in order to preserve pluripotency of 
stem cells. For instance, the loss of SOX2 is lethal to embryonic development, as the 
embryo fails to maintain an epiblast and cannot develop to a blastocyst stage [110].  
NANOG is a homeobox-containing transcription factor and more recently 
described to play a crucial role in stem cell differentiation. NANOG regulates the cell fate 
of the pluripotent inner cell mass, maintains epiblast pluripotency and prevents 
differentiation to primitive endoderm [111,112]. Absence of NANOG leads to an embryo 
lacking proper epiblast [111]. For mouse ESCs, the overexpression of NANOG maintains 
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pluripotency without the need for the extrinsic factor LIF, (which has been shown to be 
crucial in maintaining stemness of mouse ESCs in vitro [113]. ) 
 
1.2.5 Stem cell differentiation and in vitro protocols 
When the factors that conserve pluripotency are removed, stem cells undergo 
differentiation. Under specific conditions, the differentiation can be directed to generate 
progeny consisting of derivatives of the three embryonic germ layers. In vitro, the 
formation of embryoid bodies (EBs) is one of the frequently used methods to induce 
differentiation. EB formation offers the advantage of providing three-dimensional 
structure that enhances multicelllular interactions. These are demonstrated to be a crucial 
element for differentiation process [114]. There are various ways to induce EB formation; 
however, only three commonly used techniques are discussed. These include suspension 
culture in a bacterial-grade dish, hanging drop culture and methylcellulose culture.  
To induce EB formation in bacterial-grade dishes, the nontreated hydrophobic 
polystyrene dish is used [114]. This type of plate is necessary to ensure a liquid 
suspension culture and prevent cells from attaching to the surface, thus allowing cells to 
aggregate to one another.  The bacteriological dish method for differentiation has been 
successfully demonstrated in both mouse and human ESCs, in which they form various 
types of specialized cells such as cardiomyocytes and insulin-producing cells [114]. 
Despite the level of successful differentiation and simplicity of the protocol, this method 
has drawbacks. In bacterial-grade dishes, the stem cells are allowed to spontaneously 
aggregate and form varying sizes of EBs each with different cell numbers.. This causes 
the size of EBs to be heterogenous in the culture and prevents synchrony in differentiation 
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[115]. Since uniformity and homogeneity in EB morphology is often an optimal condition 
for differentiation, other methods have been developed to resolve this issue.  
The hanging drop culture overcomes the deficits of the bacterial-grade dish 
method. This method is now one of the most widely used technique to differentiate stem 
cells [116]. A specific number of cells can be seeded in the round shaped hanging 
droplets allowing a precise control of cell number in EB formation.. As the name suggests, 
the drop hangs on the petri dish lid and allows aggregation to take place. The 
disadvantage of this technique is often found in the size limit of the liquid volume and the 
complexity of the protocol. Because the droplets are hanging on the lid by surface tension, 
approximately 50 μL is the maximum volume that can be utilized. Subsequently, EBs 
from hanging drops are often transferred to suspension culture in bacteriological dishes to 
mature, thus being more laborious than the previous method [114].  
Methylcellulose culture is another technique used to induce EB formation. This 
technique was originally employed to form cell aggregates of a clonal origin [117]. 
Unlike the other methods, stem cells in the methylcellulose matrix remain as a single cell 
and these single cells will proliferate and eventually develop into EBs. The semisolid 
characteristics of methylcellulose cultures are the disadvantage of this technique as the 
matrix of methylcellulose disturbs the mass transfer of factors added during an 
experiment and this causes difficulty in handling the semisolid solution. However, 
methylcellulose culture has been successfully utilized to differentiate ESCs into 
hematopoietic cells and endothelial cells [114] (Figure 1.20).  
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Figure 1. 20. Methods of embryoid body formation. 
Embryoid body formation allows the stem cells to aggregate and enhances cell-to-cell 
interaction during the differentiation period. The three common methods include 
bacterial-grade dish, methylcellulose culture and hanging drop method. All three EB 
formation protocols permit liquid suspension of cells.  
 
 There are also differentiation techniques that do not involve the formation of EB. 
Stem cells can be cultured directly on stromal cells and differentiation can take place in 
contact with these supportive cells [118]. Stromal cells are connective tissue of organs 
and known to release growth factors that promote cell division. The most commonly used 
stromal cells in stem cells differentiation are OP9 cells. Co-culturing with stromal cells, 
however, consists of several shortcomings such as lack of knowledge with respect to the 
factors produced from the supportive cells, how these factors influence the differentiation 
process and the difficulty of isolating stem cells from stromal cells. The last protocol 
involves differentiating stem cells in a monolayer of extracellular matrix (ECM) protein. 
This type of approach is an attempt to mimic the niche microenvironment that houses 
stem cells. The ECM is a complex mixture of matrix molecules which are typically large 
glycoproteins such as fibronectins, collagens, laminins and proteoglycans that assemble 
into fibrils or other macromolecules [119]. The type of ECM could determine the fate of 
stem cell differentiation as it may influence the generation and survival of the developing 
cell types. The importance of the niche, however, is a relatively newer field in stem cell 
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research. This method therefore requires additional investigations in order to identify 
ECMs that contributes in differentiation and directing the fate of stem cells [119]. 
 
1.2.5.1 Mechanism of differentiation 
Current stem cell research focuses on identifying factors and pathways that 
contribute to the fate of stem cells during differentiation. Studies exploring modifications 
in gene expression in undifferentiated and differentiated stem cells are one of the most 
utilized methods to discover specific factors that allow stem cells to transform into 
specific cell types. For the sake of relevancy only the mechanism of mesoderm 
differentiation will be discussed in detail. 
 
1.2.5.1.1 Mesoderm differentiation 
Mesoderm is one of the major germ layers that are being studied in stem cell 
differentiation. There are several factors already identified to be important in early 
mesoderm differentiation. These factors include bone morphogenic protein-2 (BMP-2), 
BMP-4, Brachyury, Homeobox protein MIXL-1, Nodal and Snail [120,121,122]. BMP-4 
is a transforming growth factor-beta (TGF-β) superfamily member and it initiates 
complex formation of type I and type II receptors on the cell surface. This allows receptor 
II to phosphorylate the receptor I kinase domain. The phosphorylated type I receptor then 
phosphorylates Smad 1, 5, 8 (R-Smad). The two phosphorylated R-Smads and mediator 
Smad (Co-Smad) form a heterotrimeric complex, which then translocate into the nucleus. 
In the nucleus, this complex cooperates with transcription factors to modulate gene 
expressions [123] (Figure 1.21). Studies have demonstrated that this signaling cascade is 
a crucial requirement for mesoderm differentiation. Snail is another transcription factor 
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that is found to be involved in the development of mesoderm layers. Presence of this 
protein represses neuroectodermal differentiation by silencing genes such as rhomboid 
and single-minded in the mesodermal region [124]. Nodal factor has been demonstrated 
to play a role in mesodermal and endodermal differentiation. In mouse, high levels of 
nodal signaling has been suggested to be required to promote induction of posterior 
mesoderm [125].  
 
 
 
Figure 1. 21. BMP2/4 induce mesodermal differentiation. 
Binding of BMP2/4 to the receptor promotes the formation of a BMPR-1 and BMPR-2 
complex. Subsequently BMPR-2 phosphorylates BMPR-1 and allows BMPR-1 to recruit 
and phosphorylate Smad 1/5/8. Phosphorylated Smad protein can then complex with Co-
Smad and be shuttled  into nucleus to interact with other transcription factors thus 
modulating gene expression. 
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Once differentiated into mesoderm, this layer can further differentiate into 
mesenchymal, mesothelial, osteogenic, vascular, hematopoietic, cardiac cell and many 
other types. In particular, lineages such as hematopoietic and cardiac are among the 
easiest to differentiate from stem cells and have been studied in detail (Figure 1.22).  
 
Figure 1. 22. Mechanism of hematopoietic and cardiac differentiation of mesoderm layer. 
Mesoderm germ layer can differentiate into hematopoietic and cardiac cells. 
Transcription factors such as FLK-1, GATA-1 and TAL1/SCL promote hematopoietic 
differentiation. Mesp1, a master regulator of cardiac differentiation, promotes other 
cardiac related genes to promote cardiac differentiation. 
 
The presence of hemoglobinized cells in EBs was first described in 1985 [126]. 
Since then, significant interest was placed in modeling the hematopoietic commitment of 
stem cells in order to allow readily accessible supply of transplantable stem cells in 
clinical settings. Studies identified important factors and markers in differentiation of 
ESCs into HSCs. FLK-1 is known to play a key role in  hematopoietic and vascular 
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development [127]. In murine embryo, FLK-1 deficient mice do not develop blood 
vessels or yolk sac blood islands between 8 to 9 days [127]. FLK-1 positive cells express 
the GATA-1 transcription factors prior to endothelial or hematopoietic lineage markers 
[128,129], thus, indicating the importance of GATA-1 in hematopoietic differentiation of 
ESCs. The TAL1/SCL basic helix-loop-helix (bHLH) transcription factor, downstream of 
FLK-1 signaling pathway, is detected in the hematopoietic cells in later stages and in the 
yolk sac region in the mouse embryo [130]. Studies have indeed demonstrated that 
expression of TAL1 is essential for the development of all hematopoietic cells [131,132]. 
Human ESCs have also been successfully differentiated into hematopoietic cells under 
appropriate conditions. Hematopoietic development can be induced by addition of BMP4, 
Vascular endothelial growth factor (VEGF), and a mixture of hematopoietic cytokines 
such as interleukins (ILs), colony-stimulating factors (CSFs) and thrombopoietin (TPO) 
during either stromal cell-mediated differentiation or EB-mediated hematopoiesis [133]. 
Cardiomyocyte differentiation of ESCs is another mesodermal differentiation that 
is being studied extensively. In particular, investigations so far demonstrated that only 
pluripotent stem cells are capable of efficiently differentiating into spontaneously 
contracting cardiomyocyte-like cells in vitro [134]. Although the mechanism of 
cardiogenesis is still not fully understood, a number of key regulators of this process have 
been identified. Mesp1 is considered as the master regulator of cardiovascular 
development, initiating the cardiac transcription factor cascade to direct the formation of 
multipotent cardiac progenitor cells. Once Mesp1 is activated, it promotes increased 
expression of numerous other transcription factors such as Mef2c, Myocardin, Gata4, 
Nkx2.5 and Hand2 [135] (Figure 1.23). In particular, Nkx2.5 and Gata4 are crucial for 
specification of cardiac muscle phenotype differentiation. Nkx2.5 is shown to regulate the 
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transcription of several cardiac genes including α-sarcomeric actin and β-myosin heavy 
chain (β-MHC) [136]. Gata4 is a member of the cardiac GATA subfamily, consisting of 
Gata4, 5 and 6. These transcription factors bind to WGATAR motifs in promoter regions 
of cardiac- or gut-specific genes [137,138]. Once the differentiation is specified into 
cardiac lineage, the cardiomyocytes undergo a maturing phase. During this stage, several 
structural proteins are expressed such as α-actin, α-myosin heavy chain (α-MHC) and 
Troponin-T [134]. BMP-2/BMP-4 are also essential in mesodermal differentiation. These 
proteins have also been found to play a key role in recruiting mesoderm into cardiac 
lineage [139,140]. P19 clonal lines (P19C6noggin), consisting of noggin over-expression, 
exhibit hindered cardiac differentiation as noggin prevents activation of cardiac 
transcription factors and contractile proteins. It has been shown that addition of BMP 
proteins in the culture or overexpressing TAK1, a member of the mitogen-activated 
protein 3-kinase superfamily that transduces BMP signaling, can rescue P19C6noggin 
cells to differentiate into cardiomyocyte-like cells [141]. 
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Figure 1. 23. Expression of Mesp1 acts as a master regulator for cardiac differentiation. 
The green Mesp1 indicates increased expression and the red indicates decreased. Once 
the Mesp1 expression is enhanced, it induces a number of cardiac mesoderm linked gene 
expressions such as Nkx2.5, Tbx5, Mef2c, Gata4 and etc. On the other hand, Mesp1 
downregulates several genes involved in primitive streak, endodermal and hemangloblast 
genes expressions [135]. 
 
1.2.5.2 Differentiation in P19 embryonal carcinoma cells 
P19 cell lines are one of the most commonly used ECCs in stem cell research. The 
cells are derived from a teratocarcinoma formed following transplantation of 7.5 day 
embryos into the testis of C3H/He mice [142]. These isolated cells grow rapidly and are 
maintained as undifferentiated stem cells. Unlike other ECCs, P19 cells can undergo 
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efficient differentiation when the aggregates are exposed to non-toxic concentrations of a 
number of drugs . Retinoic acid (RA) and DMSO are two such drugs identified to be most 
effective in inducing differentiation of P19 cells. Both chemicals show no toxic effect to 
P19 cells at the doses used for differentiation, indicating that the drugs are not selecting 
the differentiated cells pre-existing in the cultures [142,143].  
Retinoids are ubiquitous signaling molecules affecting nearly every cell types. In 
particular, these vitamin A (retinol) derived compounds are found to have profound 
effects on development, proliferation, differentiation and apoptosis [144]. Retinoids are 
synthesized from the diet as dietary vitamin A or generated enzymatically from the 
dietary precursor β-carotene [144]. Retinol dehydrogenase 10 (RDH10) is a primary 
enzyme that metabolizes vitamin A to retinaldehyde in a NAD
+
 dependent manner. 
Retinaldehyde is then oxidized to RA via ALDH1a2 [145,146,147]. Once synthesized, 
RA is transported nucleus bound to cellular RA-binding protein 2 (CRABP2) and 
subsequently binds to the retinoic acid receptor (RAR) α, β or γ. Then the RARs can bind 
to one of the retinoid X receptors (RXRs) and promote formation of a heterodimer 
complex. This complex can bind to DNA and activates transcription of RA primary 
response genes. This step is considered to be the first step of the RA induced 
differentiation process and it occurs rapidly, within minutes to hours after the RA addition. 
The transcription factor Hoxa1 is identified as a primary response factor of this cascade. 
Primary response transcription factors are then used to promote synthesis of proteins that 
are involved in differentiation in the presence of RA [144] (Figure 1.24). In P19 ECC 
cultures, the concentrations of RA can be modified to produce all three primitive germ 
layers. Upon RA treatment of cell monolayers, P19 cells differentiate into endodermal 
and mesodermal pathways. Under suspension or aggregate conditions, however, RA 
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induces P19 cells to become neurons, glial and fibroblast-like cells. The dose of RA also 
dictates the process of differentiation. When aggregates are exposed to relatively higher 
doses (greater than 10
-7
M), the P19 cells differentiate into neurons and astroglial cells. At 
lower doses (around 10
-8
M), skeletal muscle is formed and fewer neurons are present. At 
even lower doses (around 10
-9
M), cardiac muscle is formed while the number of skeletal 
muscles decrease in the culture [97]. 
 
 
Figure 1. 24. Mechanism of retinoic acid-induced differentiation. 
Vitamin A or retinol binds to serum retinol binding proteins (sRBPs). The Stra6 then 
transports the complex into the cell and the sRBP is replaced with cellular retinol binding 
protein (CRBP)-1. The enzyme RDH10 is responsible for converting retinol into 
retinaldehyde and ALDH1a2 subsequently uses retinaldehyde to produce all-trans retinoic 
acid (ATRA). ATRA is then complexed with CRBP2 first and binds to RARs and RXRs. 
This complex is then translocated into the nucleus to modulate gene expression, 
transcriptional activation, differentiation and epigenetic changes within the cell. 
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DMSO is an extensively studied chemical agent that is known to induce 
differentiation in ESCs and ECCs. It was demonstrated that P19 cells require 0.5-1% 
DMSO in order to differentiate into a variety of endodermal and mesodermal tissues. 
Although DMSO is identified to be a cell line specific inducer, its ability to initiate 
differentiation in other cells has been demonstrated previously. These cell lines include 
friend erythroleukemia (MEL) cells, neuroblastoma cells, lung cancer cells and mouse 
ESCs [148]. Although the DMSO-induced differentiation P19 cells produce numerous 
types of cells, cardiomyocytes-like cells are studied most frequently. The mechanism of 
DMSO-induced cardiac differentiation is still not fully understood, but studies revealed 
several signaling pathways involved in this process (Figure 1.25). DMSO is suggested to 
act via the oxytocin pathway as oxytocin antagonists have been shown to interfere with 
DMSO-induced cardiac myocyte differentiation [149]. Cardiac-like cells generated from 
P19 cells express similar transcriptional factors and signaling pathways observed in 
cardiac differentiation of ESCs. Gata4, Mef2c, Nkx2.5 and Tbx5 have been identified to 
be the crucial factors in DMSO-induced cardiomyocyte-like differentiation of P19 cells, 
which has also been found to play a key role in ESC-derived cardiac differentiation, [150]. 
The increased expression of BMP and TAK1 have also been identified during DMSO-
induced differentiation, thus further indicating the similarity between the P19-derived and 
ESC-derived cardiomyocytes [148]. 
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Figure 1. 25. Mechanism of DMSO-induced differentiation. 
DMSO is demonstrated to act through the oxytocin/oxytocin receptor (OTR) pathway. 
Binding of DMSO to OTR causes intracellular calcium ion concentration to increase and 
causes increase in nitric oxide (NO) level via modulating the activity of nitric oxide 
synthase (NOS). This in turn increases the amount of cGMP. The pathway ultimately 
influences cardiac differentiation by inducing the expression of Gata4, Mef2c, Nkx2.5 
and Tbx5 [151]. 
 
1.2.6 Metabolism and stem cell differentiation 
Currently, the investigation to understand the molecular mechanisms of stem cell 
differentiation primarily relies on identifying the changes in gene expression, 
transcription factor expression and epigenetics. Evaluation of the global gene expression 
and identifying the key transcription factors in differentiation has provided important 
information about the process of differentiation. Although understanding the underlying 
genetic and epigenetic factors are crucial, other molecular aspects must be delineated in 
order to fully construct and identify the mechanisms governing cellular differentiation. 
Metabolomics is one of the emerging fields that show promising complementary to the 
other techniques in the exploration of the stem cell characteristics [152]. Among the 
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metabolic compartments, mitochondrial metabolism is studied most extensively in an 
attempt to link metabolism to stem cell differentiation. 
 
1.2.6.1 Mitochondrial metabolism and differentiation 
Although there are studies indicating the participation of the mitochondrion during 
differentiation, its precise role has yet to be fully uncovered. There is mounting evidence 
demonstrating the significance of mitochondrial morphology, biogenesis and activity 
during this process. In both human and mouse ESCs, undifferentiated stem cells consist 
of few and poorly developed cristae containing mitochondria [153]. These mitochondria 
were found to be localized perinuclearly [154]. Once differentiated and matured, however, 
these cells contain higher mitochondrial DNA content and mass [155,156]. The up-
regulation of energy production via oxidative metabolism has been demonstrated in 
differentiated cells. For instance, oxidative phosphorylation was suggested to be crucial 
for the functional excitation-contraction in cardiac cells [157]. Neural and cardiac 
differentiation of ESCs was substantially increased when the differentiating cells were 
exposed to the natural metabolites associated with oxidative metabolism [152,158,159]. 
These findings suggest that mitochondria experience drastic changes in morphology and 
activity during the differentiation process. Despite these findings, the studies often fail to 
delineate the possible role of mitochondrial modification and oxidative metabolism in 
regulating differentiation. 
 
1.2.6.2 Nuclear metabolism and differentiation 
In contrast to well understood metabolic networks in the mitochondria, nuclear 
metabolism remains relatively elusive to date. There are several nuclear residing 
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metabolic enzymes and cofactors that have been recently identified. As these enzymes are 
metabolism-linked, the roles of these proteins are often suggested to be related to 
modulating metabolic status of the cells by regulating specific gene expression. There are, 
however, limited studies dedicated to  understanding the nuclear metabolism in stem cell 
differentiation. Recently, ACL has been shown to play a role in histone acetylation during 
differentiation of murine 3T3-L1 preadipocyte into adipocyte [73]. O-linked N-
acetylglucosamine (OGlcNAc) transferase (OGT) activity is found to be essential in ESC 
viability and development. Nuclear OGT of ESCs forms a stable partner with ten-eleven 
translocation-1 (TET1) and regulates CpG island methylation. This in turn modifies 
several important transcriptional regulators such as SP1, HCFC1, MYC and OCT4 [160]. 
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2. Thesis objectives 
 
The objective of this study is to investigate the role of metabolism in the 
differentiation of stem cells. Although genomic and transcriptional studies have been 
explored, there is limited information on the functional proteomics and metabolomics of 
differentiating stem cells. Using P19 embryonal carcinoma cells as a model, cytoplasmic, 
mitochondrial and nuclear metabolism were analysed. The alterations in glycolytic and 
mitochondrial enzymes and the fluctuation in metabolite levels involved in the central 
energy metabolism were studied. The variations in the nature and concentrations of 
metabolites coupled with activities of key enzymes involved in ATP synthesis provide a 
holistic illustration of all the participants in the DMSO-induced differentiation process. 
The significance of nuclear metabolism in pluripotency and the final fate of stem cells in 
response to nuclear metabolism are only beginning to emerge. The modulation of NAD
+
, 
a key contributor to epigenetic changes was probed. Particular attention was given to the 
role of lactate dehydrogenase (LDH) and NAD
+
 in epigenetic changes. Sirtuins are 
known to modify histone by removing acetyl groups, thus controlling the flow of genetic 
information. Such a role of LDH will help establish the intimate connection between 
cellular metabolism and epigenetic modulation. This investigation will assist in 
generating a global perspective on how metabolism, the end-product of any genetic cue, 
is indeed an important communicator and regulators of stem cells. This information will 
be pivotal in designing technologies that allow guiding pluripotent cells to any desired 
destination. 
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3. Materials and Methods 
3.1 Cell culturing 
3.1.1 P19 embryonal carcinoma cells 
P19 embryonal carcinoma cells CRL-1825 were acquired from the American 
Type Culture Collection (ATCC). The cells were maintained in α-minimum essential 
media (α-MEM) supplemented with 5% fetal bovine serum (FBS) and 1% antibiotics 
(streptomycin and penicillin) in an incubator kept at 37˚C with a 5% CO2 humidified 
atmosphere [161].  
 
3.1.2 Culture initiation and passaging 
P19 cells were cryogenically frozen in 5% DMSO. Prior to use, the frozen cells 
were thawed in a 37˚C water bath. Once thawed, the cells were pelleted at 2000 RPM for 
5 minutes (Sorvall Legend RT Centrifuge). The media was removed and the pellet was 
resuspended in 1 mL of α-MEM + 5% FBS + 1% antibiotics (Growth media). The cells 
were seeded into a 75 cm
2
 tissue culture flask in a final volume of 10 mL growth medium. 
The cells were allowed to grow for 2 days, until confluent. Cultures were then passaged 
by removing the adherent cells via trypsinization (1X trypsin in phosphate buffer saline 
(PBS, [136 mM sodium chloride, 2.5 mM potassium chloride, 1.83 mM dibasic sodium 
phosphate and 0.43 mM monobasic potassium phosphate, pH 74.]). The cells were then 
diluted to 1.0x10
6
 cells/mL and seeded into a new 75 cm
2
 culture flask containing 10 mL 
total volume of growth medium. Each culture was maintained until the passage number 
was 30 (Figure 3.1) 
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3.1.3 Cell storage 
The cells from first, second and third passages were isolated for cryogenic storage. 
The cells were detached from the flask by trypsinization and centrifuged at 2000 RPM for 
10 minutes at 4˚C (Sorvall Legend RT Centrifuge). Low speed centrifugation prevents 
plasma membrane damage. The supernatant was removed and the pellets were rinsed with 
PBS. The pellets were then resuspended in 2 mL of DMSO containing cell storage media 
(Gibco) and aliquoted into 2 mL cryovials. The cells were frozen first at -20˚C for 2 hours 
followed by 1 day at -80˚C prior to cryogenic storage to avoid rapid freeze fracturing of 
the cells. 
 
3.1.4 Differentiation 
The protocol for DMSO-induced differentiation of P19 ECCs was performed as 
described in [149,162]. To induce differentiation, 1x10
6
 undifferentiated cells were 
seeded in a 10 cm bacteriological petri dish with a total volume of 10 mL growth medium 
under standard conditions of 5% CO2 at 37˚C. The petri dishes were covered with a thin 
layer of 1% agar to prevent adhesion of the cells. DMSO was added to a final 
concentration of 1% and cells were allowed to form EBs (day 0). After 2 days, the 
medium was removed carefully and replaced with 10 mL of fresh medium with DMSO. 
Cells were then incubated for an additional 2 days (day 4). At day 4, the cells were either 
isolated or plated for further analysis (Figure 3.1) [149,162]. OCT4 expression was 
monitored via western blot to assess the differentiation. 
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Figure 3. 1. Cell growth and differentiation. 
P19 cells were thawed from a cryogenic stock and grown until confluent (approximately 
2 days). Cells are either propagated or subjected to differentiation. To differentiate, P19 
cells were trypsinized and the cell number was counted. 1 x 10
6
 cells were seeded per 
agar-coated petri dish to allow aggregation (day 0). By day 4, the embryoid bodies were 
disaggregated and either isolated or seeded in new flasks for maturation. 
 
To plate EBs, the day 4 aggregates of P19 cells were transferred to a 50 mL tube 
and centrifuged at 2000 RPM for 5 minutes. Subsequently, the media was removed and 
the cells were washed with PBS. The pellets were then subjected to 25% trypsin in PBS 
and incubated at 37˚C for 5 minutes. The pellets were gently resuspended, promoting 
disaggregation. Afterwards, 5 mL of fresh growth medium was added to deactivate the 
trypsin. The cells were centrifuged at 2000 RPM for 10 minutes and the supernatant was 
discarded (Sorvall Legend RT centrifuge). The cell pellets were resuspended in fresh 
media and counted. For plating, cells were seeded at 2x10
6
 cells in a 75 cm
2
 tissue culture 
68 
 
grade flask. The media was replenished every 2 days in order to provide fresh nutrients 
and remove waste products. 
 
3.1.5 Cell isolation and subcellular fractionation 
Cells were isolated at day 3, day 4 and day7 throughout the differentiation process. 
The aggregates (day 3 and day 4) were transferred to the centrifuge tubes immediately. 
Plated cells (day 7), however, were isolated by trypsinization and gentle tapping of the 
flask. The cells were removed from the medium by centrifugation at 2000 RPM for 10 
minutes (Sorvall Legend RT Centrifuge). The pellets were washed twice in ice-cold PBS 
then resuspended in 1 mL of ice-cold mammalian cell storage buffer (mCSB) [50 mM 
Tris-HCl, 1 mM phenylmethylsulfonylfluoride, 1 mM dithiothreitol, 250 mM sucrose, 1 
mg/mL pepstatin, 0.1 mg/mL leupeptin, and 2 mM citrate, pH 7.4] and stored at -80˚C. 
When the cells were needed, they were thawed and centrifuged at 400 x g for 10 
min at 4C. The cells were then resuspended in 30μL of mCSB and homogenized on ice 
with a sonic dismembrator operating at 36% amplitude. The sonication was performed 4 
times for 10 seconds in 1 second bursts to disrupt the cell membrane. The suspension was 
kept on ice for 5 minutes between each round of sonication to prevent damage to 
intracellular organelles and proteins. The subcellular fractions were obtained by using 
differential centrifugation [163].  
Whole cells were first removed by centrifugation at 150 x g for 10 min at 4˚C. 
The supernatant containing cell free extract (CFE) was centrifuged at 800 x g for 20 
minutes at 4˚C to produce a nucleus pellet. The pellet was resuspended in 50 μL of mCSB 
before being processed for further experimentation. The supernatant was further 
centrifuged at 12,000 x g for 45 minutes at 4˚C to isolate mitochondria from the 
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remaining CFE. The mitochondrial fraction was resuspended in 50 μL of mCSB (Figure 
3.2). Purity of these fractions was ascertained by anti-actin (for nucleus, anti-voltage 
dependent anion channel (VDAC) (for mitochondria) and Lamin B1 (for nucleus). 
 
Figure 3. 2. Subcellular fractionation 
Cells are isolated and resuspended in 1 mL of mammalian cell storage buffer (mCSB) and 
stored at -80˚C until needed. When the cells were needed, they were thawed and the pellet 
was isolated by centrifugation at 400 x g. The pellet was resuspended in 50μL of mCSB 
then sonicated 3 times. Whole cells were removed and supernatants were centrifugated at 
800 x g for 20 minutes to yield a nuclear pellet. Supernatant was again spun down at 
12,000 x g for 45 minutes to obtain a mitochondrial pellet and cytoplasmic fraction. 
 
3.2 Blue native polyacrylamide gel electrophoresis 
BN-PAGE was used to perform functional proteomics on metabolic enzymes. 
This technique provides a unique tool to monitor enzymatic activities in their native state 
(Figure 3.3) [164]. Subcellular protein fractions were quantified and normalized by the 
Bradford assay [165]. Protein was diluted to its desired concentration in blue native buffer 
(1.5 M €-aminocaproic acid, 150 mM BisTris (pH 7 at 4oC)]. To the mitochondrial 
fraction, 10% maltoside, a mild detergent, was added to release membrane-bound proteins 
while maintaining their activity. Samples were kept on ice for 30 minutes in order to keep 
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proteins native during maltoside treatment. Prepared proteins were stored at -20˚C for up 
to one week before usage. 
 
 
Figure 3. 3. Blue native polyacrylamide gel electrophoresis. 
Subcellular fractions can be isolated and prepared for BN-PAGE analysis. a) Coomassie 
G-250 dye prevents protein aggregation in membranous proteins, while maintaining their 
protein-protein interactions. b) BN-PAGE separates proteins based on their size and 
maintain their native conformation during electrophoresis [164]. 
 
3.2.1 Gel formation 
Native polyacrylamide gel electrophoresis gels were formed by a modified 
method described in [166]. Gels (dimension 8x7cm
2
) were cased using 1 mm spacers in 
the Bio-Rad MiniProtean
TM
2 system. A 4-16% gradient gel was used in all blue native 
polyacrylamide gel electrophoresis (BN-PAGE) experiments. The 4% acrylamide gel 
solution was made separately from 16% acrylamide gel solution and mixed using a 
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gradient former and a peristaltic pump to create a 4-16% resolving gel. A stacking gel 
was poured over the resolving gel after the gel was solidified (Table 3.1). 
 
Table 3. 1. Reagents for gradient BN-PAGE gel 
Volume of reagents required to compose resolving and stacking gels. 
Reagent 16% 4% Stacking Gel 
48% Acrylamide 
+1.5% Bisacrylamide 
1879 μL 234 μL 273 μL 
3X BN Buffer 967 μL 967 μL 1136 μL 
ddH2O 654 μL 1699 μL 2000 μL 
75% (v/v) Glycerol 773 μL - - 
10% (w/v) APS 7.4 μL 9.4 μL 50 μL 
TEMED 3 μL 3 μL 10 μL 
 
3.2.2 Electrophoresis 
The prepared BN-PAGE protein samples were introduced into the wells along 
with molecular mass standards (Apo-ferritin = 480kDa, BSA = 120kDa and 66 kDa). The 
molecular weight standards are used to ensure that gels resolve appropriately. The gel 
cassettes were then assembled in the Bio-Rad MiniProtean
TM
2 system. Once the proteins 
were loaded, the gel was overlaid with blue cathode buffer. The inner chamber of the 
electrophoresis system was then filled with the coloured cathode buffer and the outer 
chamber was filled with clear anode buffer (Table 3.2). Coomassie staining was used to 
ensure the equal loading of proteins. 
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Table 3. 2. Reagents for BN-PAGE 
Composition of solutions required for BN-PAGE electrophoresis. Note: pH correction of 
blue cathode, clear cathode and anode buffers must be performed at 4˚C 
 
Reagent Blue Cathode 
Buffer 
Colourless 
Cathode 
Buffer 
Anode Buffer 3X Blue 
Native 
Buffer 
Tricine (mM) 50 50 - - 
Bis-Tris (mM) 15 15 50 150 
Coomassie Blue 
G-250 (%) 
0.002 -/0.002 - - 
pH 7.0 7.0 7.0 7.0 
 
The electrophoresis was performed at 4˚C to prevent denaturation of proteins. 
Electrophoresis was performed at 80 V to allow proteins to properly stack prior to 
resolving gel. Upon reaching the resolving gel, the voltage was increased to 150 V and no 
higher than 25 milliamps. When the proteins had run halfway through the gel, the blue 
cathode was replaced with a colourless cathode. The removal of coloured cathode allows 
visualization of the gel and partially removes the stain, so the activity band could be 
visualized more readily. 
 
3.2.3 In-gel activity assays 
Upon completion of electrophoresis, the gel slab was removed carefully from the 
unit and placed in reaction buffer [25 mM Tris, 5 mM MgCl2, pH7.0] for 15 minutes in 
order to remove remaining buffer salts. Subsequently, the gels were placed in reaction 
mixture and kept at 37˚C in the dark. Each reaction container contained a reaction 
mixture containing substrates, cofactors and linking enzymes specific to the enzymes 
under investigation. The reaction was stopped with destaining solution [50% methanol, 
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10% glacial acetic acid, 40% ddH2O] which helped remove the coomassie staining on the 
gel. The reaction mixtures for each enzyme are elaborated in table 3.3. 
 
Table 3. 3. Enzymatic activity reaction mixtures 
Enzyme Reaction Mixture Reaction Type 
Glucose 6-phosphate 
dehydrogenase 
[EC 1.1.1.49] 
5 mM glucose 6-phosphate 
0.5 mM NADP
+
 
0.3 mg/mL PMS 
0.5 mg/mL INT 
NAD(P)H producing 
reaction 
Isocitrate dehydrogenase-
NAD(P)
+
 
[EC 1.1.1.41] 
[EC 1.1.1.42] 
5 mM isocitrate 
0.5 mM NAD(P)
+
 
0.3 mg/mL PMS 
0.5 mg/mL INT 
NAD(P)H producing 
reaction 
Malate dehydrogenase 
[EC 1.1.1.37] 
5 mM malate 
0.5 mM NAD
+
 
0.3 mg/mL PMS 
0.5 mg/mL INT 
NAD(P)H producing 
reaction 
Malic enzyme 
[EC 1.1.1.82] 
5 mM malate 
0.5 mM NADP
+
 
0.3 mg/mL PMS 
0.5 mg/mL INT 
NAD(P)H producing 
reaction 
Lactate dehydrogenase 
[EC 1.1.1.27] 
5 mM lactate 
0.5 mM NAD
+
 
0.3 mg/mL PMS 
0.5 mg/mL INT 
NAD(P)H producing 
reaction 
Pyruvate kinase 
[EC 2.7.1.40] 
5 mM phosphoenolpyruvate 
0.5 mM ADP 
0.5 mM NADH 
2.8 μg/mL DCIP 
0.5 mg/mL INT 
 
3.3 units/mL lactate 
dehydrogenase 
Enzyme linked reaction 
(LDH linked) 
ATP-citrate lyase 
[EC 2.3.3.8] 
20 mM citrate 
0.75 mM CoA 
0.37 mM ATP 
1.5 mM NADH 
2.8 μg/mL DCIP 
0.5 mg/mL INT 
 
13 units/mL malate 
dehydrogenase 
Enzyme linked reaction 
(MDH linked) 
Complex I 5 mM NADH NADH oxidation reaction 
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[EC 1.6.5.3] 0.5 mg/mL INT 
Complex IV 
[EC 1.9.3.1] 
10 mg/mL diaminobenzidene 
10 mg/mL cytochrome C 
562 mg/mL sucrose 
Diaminobenzidene 
reduction 
 
 Four types of reaction are studied, including NAD(P)H producing, LDH linked, 
MDH linked, NADH oxidation and diaminobenzidene reduction reactions. NAD(P)H 
generating enzymes are visualized when NAD(P)H transfers electrons to INT using PMS 
as a electron mediator. The reduced INT forms an insoluble red formazan precipitate at 
the region where the enzyme is active (Figure 3.4) [167]. 
 
 
Figure 3. 4. NAD(P)H producing enzyme activity assay. 
Reduction of NAD(P)
+
 to NAD(P)H via an enzymatic reaction. NAD(P)H then transfers 
electrons to reduce PMS which reduces INT. Reduced INT forms a red-formazan 
precipitate. 
 
 LDH and MDH-linked enzymatic activity assays uses exogenous MDH and LDH 
to detect the enzyme of interest. MDH and LDH will then reduce NAD
+
 to form NADH 
or oxidize NADH to NAD
+
. The former reaction leads to the reduction in PMS and the 
latter uses DCIP as an electron mediator to reduce INT (Figure 3.4) [76,167]. 
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a) 
 
b) 
 
Figure 3. 5. Malate dehydrogenase and lactate dehydrogenase-linked enzyme activity 
assays. 
 
a) Pyruvate formed by an enzyme of interest is used by exogenous LDH. Electrons are 
transferred from NADH to INT to produce a formazan precipitate. b) An enzyme of 
interest produced oxaloacetate which can then be metabolized by exogenous MDH. DCIP 
serves as an intermediate to reduce INT from the MDH reaction and create the formazan 
precipitate. 
 
 The activity of Complex I and Complex IV of the electron transport chain was 
monitored. Although Complex I oxidizes NADH, it does not require an electron mediator 
such as PMS or DCIP as the reaction itself has sufficient electropotential to reduce INT. 
The in-gel activity of cytochrome C oxidase (Complex IV) was examined via the 
reduction of diaminobenzidene [76]. The latter accepts the electrons from cytochrome C 
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and undergoes oxidative polymerization at the site of enzyme activity. This polymer of 
diaminobenzidene is insoluble and precipitate out of the solution with a brown colour. 
Enzymes probed in this study are illustrated in figure 3.5. 
 
 
Figure 3. 6. Enzymatic activities probed in various cellular compartments. 
Enzymes of central metabolism and nuclear metabolic enzymes were probed via BN-
PAGE. Glycolysis and the pentose phosphate pathway were studied in the cytoplasm. 
TCA cycle and electron transport chain enzymes were analyzed in the mitochondria. 
Nuclear lactate dehydrogenase, ATP-citrate lyase and pyruvate kinase was examined in 
the nucleus. 
 The enzyme activity was confirmed by HPLC analysis. The activity band was 
excised from the gel and placed in a reaction mixture containing the appropriate 
substrates for 30 min (refer to activity assay recipe in Table 3.3). The consumption of 
substrates and formation of products was monitored by HPLC. 
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3.3 HPLC analysis 
Samples were filtered and diluted ten-fold with Milli-Q water prior to HPLC 
analysis. These were then placed in the automated sampler of the Waters 2695 Aliance 
HPLC. The EMPOWER software allowed programming of the protocol and automatic 
injection of the samples. Prior to the 30 min sample injections, the column was 
equilibrated for 10 min. The volume of sample injected was between 50 to 100 μL 
depending on the desired resolution of the peaks. The HPLC was standardized using a 
five-point calibration protocol prior to each injection. A Phenomenex C-18 column with a 
polar cap was used in conjunction with HPLC grade mobile phase (20 mM KH2PO4, pH 
of 2.9) to retain organic acids. A Waters 2487 dual λ absorbance detector operating at 210 
nm for carbonyl functions, and 254 nm, for C to N conjugation, was used to detect the 
organic acids. The flow rate was kept at 0.7 mL/min for all experiments. The identities of 
the peaks were determined by comparing to know standards and by spiking the samples 
with specific standards to confirm their identity.  
 
3.3.1 CFE, cytoplasmic and mitochondrial fractions 
Both control and DMSO-differentiated subcellular fractions were collected and 
analyzed. Samples were equalized by the cell counts performed prior to isolation (e.g., 
subcellular fractions were obtained from same amount of control and DMSO cells). All 
subcellular fractions were subjected to two analyses: 1) metabolic profile and 2) the 
monitoring of specific substrate consumption. The CFE was treated with 2 mM 
acetoacetate and 2 mM succinate in order to assess the substrate consumption. To 
examine the ATP producing ability of the mitochondria, the mitochondrial fractions were 
subjected to 2 mM succinate or 2 mM malate with 0.5 mM ADP for 1 hour.   
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3.3.2 Nuclear fraction 
To analyse nuclear fraction form the control and differentiated cells, nuclear 
proteins were isolated from an equal cell number of both control and DMSO-treated cells. 
A metabolic profile of the nucleus was first obtained to assess the level of metabolites 
present. The nuclear NAD
+
 consumption was monitored by incubating nuclear fractions 
with 0.5 mM NAD
+
 for varying period of time at 37˚C in reaction buffer. Subsequently, 
the nuclear proteins were boiled for 10 minutes to lyse the nuclei. Solid materials were 
then removed by centrifugation and filtered prior to sample injection in the HPLC. 
 
3.4 Histone acetylation 
Histone extraction and purification was performed as outlined in [168]. Cells were 
grown and were pelleted at 300 x g for 10 minutes. The pellets were washed with PBS 
and again subjected to centrifugation at 300 x g for 10 minutes. Cells were then 
resuspended in 1 mL of hypotonic lysis buffer [10 mM Tris-HCl, 1 mM KCl, 1.5 mM 
MgCl2, 1 mM DTT, 1 mg leupeptin and 0.5 μL pepstatin, pH 8.0] and incubated on a 
rotator for 30 minutes at 4˚C to promote swelling and lysis by mechanical sheering. Next, 
a nuclear pellet was obtained by centrifugation at 10, 000 x g for 10 minutes at 4˚C. The 
supernatant was discarded and nuclei were resuspended in 400 μL of 0.4 H2SO4 and 
incubated on a rotator at 4˚C overnight. Histones were precipitated from the supernatant 
(400 μL) by adding 132 μL of ice cold trichloroacetic acid drop-wise at a final 
concentration of 33%. The samples were left on ice overnight and centrifuged the next 
day at 16, 000 x g for 10 minutes at 4˚C. The histone pellets were washed twice with ice 
cold acetone and centrifuged at 16, 000 x g for 5 minutes at 4˚C in order to completely 
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remove the acid. The remaining acetone was dried at room temperature for 20 minutes 
and the pellets were resuspended in 50 μL of ddH2O.  
To determine the level of acetylation on histones, the acetyl groups were removed 
by hydrolysing the histones. The hydrolysis step includes incubating histones in 6 N 
H2SO4 at 100˚C for 5 hours [169]. Following hydrolysis samples were prepared for HPLC 
analysis (Figure 3.6). 
 
Figure 3. 7. Histone extraction and hydrolysis protocol. 
Cells were collected and lysed using hypotonic lysis buffer and nuclei were isolated by 
centrifugation at 10, 000 x g for 10 minutes. Nuclei were resuspended in 0.4N H2SO4 and 
allowed to rotate overnight at 4˚C. Cellular debris was removed from the soluble histones 
by centrifugation at 16, 000 x g for 10 minutes. Histones were precipitated by TCA 
precipitation and centrifuged at 16, 000 x g for 10 minutes at 4˚C. The pellet was washed 
with acetone and allowed to dry.  Histones were resuspended in a solution of 6N H2SO4 at 
100˚C for 5 hours. Histone acetylation levels were measured by analyzing acetate by 
HPLC [168]. 
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3.5 Fluorescence microscopy 
After day 4 of differentiation, embryoid bodies were disaggregated and transferred 
to glass coverslips in a 35 mm X 10 mm petri plate or in 96 well plates. Cells were seeded 
at a density of 4.0 x 10
5
 cells/mL in 2 mL of growth media. It was essential to seed the 
proper cell number as high cell density causes cell clumping prior to the attachment. The 
analysis of fluorescence microscopy was performed on a Zeiss deconvolution microscope 
at 60X ocular magnifications and in the dark to prevent photobleaching. An OdysseyTM 
infrared imager from LiCor was used to visualize 96-well plates during in-cell western 
blots.  
 
3.5.1 Rhodamine dye 
Rhodamine dye was used to visualize membrane potential generated in 
mitochondria. Rhodamine B fluoresces when it is protonated by the acidic gradient 
created by active mitochondria, thus making this dye ideal to observe the mitochondrial 
activity level in the cell. The cells grown on the coverslips were incubated with 
rhodamine B (15μg/mL in 2 mL of growth media) for 30 minutes at 37˚C, followed by 
PBS/EDTA wash [76]. 
 
3.5.2 Immunofluorescence microscopy 
At a predetermined time, the growth media was removed and the cells were 
washed twice with PBS. Cells were then fixed with a 3:1 methanol:acetic acid solution 
for 10 minutes and air-dried for 1 minute. The cells were washed with PBS twice prior to 
Hoescht 33528 (2.5 μg/mL in PBS) treatment for 10 minutes. Hoescht is used to visualize 
the nucleus. Cells were washed twice with tris buffered saline (TBS) [2.42g Tris, 8g NaCl 
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in 1 L ddH2O, pH 7.6] before the blocking step [TBS + 1% tween-20 + 5% FBS]. Tween 
serves to permeabilize the membrane for antibody binding and FBS is responsible for 
blocking non-specific binding sites. Blocking was done for an hour on a gentle agitator. 
The coverslips were washed 3 times for 5 minutes after removing the blocking solution. 
The cells were then exposed to the primary antibody (anti-OCT4 1:800, anti-VDAC 
1:1000) at an appropriate dilution in 1% tween-20 TBS (TTBS) for 2 hours on gentle 
agitation at room temperature. After three washings with TBS for 5 minutes, the cells 
were incubated with secondary antibody (dilution 1:10000 in TTBS) for1 hour (table 3.4). 
Next, the secondary antibodies were washed away with TBS three times for 5 minutes 
and the coverslips were mounted on slides. Hoescht was measured at λexcitation = 355 nm 
and λemission = 495 nm and FITC was detected at λexcitation = 495 nm and λemission = 520 nm 
[76].  
 
3.5.3 Ninety six-well plate in-cell western blot 
In-cell western assays were performed as described in the Odyssey Infrared 
Imaging System protocol document (LiCor doc# 988-08332). Embryoid bodies were first 
disaggregated and seeded in 96-well plates at 1.0x10
6
 cells/mL. After 24 hours, the cells 
were washed three times with PBS and fixed with 37% formaldehyde for 20 minutes at 
room temperature. Then, the cells were rinsed with 0.1% tween-20 in PBS and blocked 
using Odyssey blocking buffer for 2 hours. Following the blocking step, the cells were 
exposed to primary antibody overnight at 4˚C. Primary antibodies were diluted to 1:200 
in blocking buffer (anti-LDH, anti-acetylated lysine, anti-SIRT1). Secondary antibody 
(1:500 dilution in blocking buffer) incubation was performed for 2 hours with gentle 
shaking in the dark. The infrared signals were detected with an Odyssey Infrared Imager. 
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3.6 SDS-PAGE 
All protein samples were prepared in 6X sample buffer [62.5 mM Tris-HCl, 2% 
(w/v) SDS and 2% (v/v) β-mercaptoethanol, pH 6.8] at a final protein concentration of 1 
mg/mL in a 30 μL volume. Samples were boiled for 10 minutes and subjected to 
electrophoresis. A 10% isocratic SDS gel was used for protein separation [9.2% (w/v) 
acrylamide, 0.8% (w/v) bis-acrylamide, 0.15M Tris-HCl, 0.1% (w/v) SDS, 0.17% (v/v) 
TEMED, 0.86% APS, pH 8.8]. Stacking gel [9.2% (w/v) acrylamide, 0.8% (w/v) bis-
acrylamide, 0.15M Tris-HCl, 0.1% (w/v) SDS, 0.17% (v/v) TEMED, 0.86% APS, pH 6.8] 
overlayed the resolving gel. The pH difference between the stacking and resolving gel 
allows proper stacking of the proteins. Electrophoresis was done in an electrophoresis 
buffer [0.025 mM Tris, 0.192 mM glycine, 0.1% (w/v) SDS, pH 8.3] and electrophoresed 
at 80V until the protein reached into the resolving gel. Once the protein entered the 
resolving gel, the voltage was increased to 150 V until completion. The gels were 
subjected to either Coomassie staining or immunoblot assays. 
 
3.6.1 Coomassie staining 
The gels were subjected to fixing solution containing 50% methanol, 10% acetic 
acid and 40% ddH2O. After 45 minutes, fixing solution was removed and 0.2% 
Coomassie Brilliant Blue R-250 solution was added and the gels were incubated for 45 
minutes at room temperature. Destaining was performed until the desired resolution of the 
bands was achieved [170]. 
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3.6.2 Immunoblotting  
Protein expression levels were determined using SDS-PAGE followed by Western 
blotting. After SDS-PAGE electrophoresis, the resolving gel was incubated in protein 
transfer buffer (PTB) [3.03g Tris-base, 14.4 glucine in 1 L ddH2O] for 15 minutes. Two 
sponges, 2 Whatman
TM
 papers and a nitrocellulose membrane were submerged in PTB 
prior to assembling the protein transfer apparatus. Nitrocellulose membrane was placed 
between two pieces of Whatman paper
TM
 with sponges on either side. A Biorad Mini-
Trans Blot
TM
 transfer unit was used to perform protein transfer from the gel to the 
nitrocellulose membrane. The unit was subjected to a constant voltage of 25 V for 16 
hours at 4˚C. Subsequently, the membrane was removed and washed three times with 
TTBS then placed in 5% non-fat skim milk in TTBS for 1 hour in order to block non-
specific binding sites. Following the blocking, the membrane was washed twice for 10 
minutes in TBS then probed with the primary antibody at an appropriate concentration for 
2 hours (table 3.4). Following this step, the membrane was washed three times with 
TTBS for 10 minutes and subjected to secondary antibodies at an appropriate 
concentration for 1 hour (table 3.4). The membrane was washed three times with TTBS 
for 10 minutes prior to analysis on Odyssey
TM
 infrared imager. The gel was scanned with 
the Odyssey
TM
 software which detected an infrared signal from the infrared conjugated 
antibody at λexcitation=778nm, λemission=795nm (IR 800) or λexcitation=676nm, λemission=693nm 
(IR 680) [171]. 
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Table 3. 4. Antibodies 
List of primary and secondary antibodies and their dilutions. 
1˚ Antibody Dilution 2˚ Antibody Dilution 
 anti-VDAC/Porin 1/200 Anti-mouse FITC 1/500 
Goat anti-LDH 1/700 Anti-goat FITC 1/500 
Rabbit anti-
acetylated lysine 
1/200 Anti-rabbit FITC 1/500 
Rabbit anti-SIRT1 1/200 Anti-rabbit FITC 1/500 
 
3.7 LDH siRNA 
To decrease the expression of nuclear LDH in P19 cells, these were plated in 75 
cm
2
 culture grade flask and grown to 80-90% confluency in α-MEM with 5% FBS in the 
absence of antibiotics at standard culture conditions. Antibiotics are known to cause cell 
death during transfection. The siRNA solution was prepared as described in the 
manufacturer’s protocol with adjusted volumes. Solution A included 25 μL of siRNA 
duplex or negative control siRNA (ctrlRNA) diluted in 475 μL of transfection medium. 
Solution B was comprised of 25 μL of transfection reagent in 475 μL of transfection 
medium. Solution A and B was combined and incubated for 30 minutes at room 
temperature. The cells were rinsed with 3 mL of transfection medium and the mixture of 
Solution A and B was added to the culture flask. The cells were overlaid for 6 hours at 
37˚C in 5% CO2. After, 2X FBS and 2X antibiotics-containing α-MEM was added 
without removing the transfection mixture. The cells were incubated for an additional 24 
hours. The cells were either isolated at this stage or subjected to differentiation as 
described previously. Histones were extracted and purified from all samples and the level 
of histone acetylation was determined by HPLC analysis as described previously (Figure 
3.7). 
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Figure 3. 8. siRNA inhibition experiment. 
P19 cells were treated with control scrambled RNA and LDH siRNA as described by the 
manufacturer. After transfection, cells were incubated for another 24 hours. These cells 
were either isolated for histone acetylation analysis by HPLC as described previously or 
the cells were seeded for differentiation. Embryoid bodies were then isolated at day 2 and 
the level of histone acetylation was analysed. Note: embryoid bodies were only treated for 
2 days in order to conserve the effect of LDH siRNA. 
 
3.8 Statistical analysis 
The student T-test was performed to determine the significance of results between 
control and differentiated cells. All experiments were performed at least in biological 
duplicates with 3 experimental replicates of each. The confidence interval of 95% was 
chosen (p≤0.05). 
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4. Results 
4.1 Assessment of differentiation with OCT4 expression 
DMSO is an established differentiating agent for P19 embryonal carcinoma cell 
lines [148]. DMSO (1%) was used during EB formation throughout the experiments 
(Figure 4.1). At day 4, cells were isolated and cell free extract (CFE) were subjected to 
western blot analysis for OCT4 expression. OCT4 is a master regulator of pluripotency 
and the expression level of OCT4 diminishes upon induction of differentiation [101]. The 
expression level of OCT4 was indeed shown to be decreased under 1% DMSO exposure 
(Figure 4.1). 
 
Figure 4. 1. Western blot analysis of OCT4 expression. 
EBs of control and DMSO-treated cells were isolated at day 4 of differentiation. The 
OCT4 expression was examined in order to assess whether DMSO induced differentiation. 
HSP60 was used as a loading control. A representative electrogram is depicted.  
 
4.2 Mitochondrial metabolism 
4.2.1 Metabolic profile of CFE 
To examine the change in metabolism, HPLC analysis was performed on CFE of 
undifferentiated (control) and differentiated (DMSO-treated) cells. Day 3 and day 7 was 
also chosen in order to demonstrate the change in metabolism as differentiation 
progressed. A number of metabolite standards were also subjected to analysis for peak 
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identity (Figure 4.2) 
 
a)  
  
b)  
 
Figure 4. 2. Metabolite profile of differentiating stem cells.  
a) HPLC analysis of day 4 CFE of the control and DMSO-treated cells. b) CFE 
metabolites in day 3 and day 7 of differentiation expressed as percentage of the control. 
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The negative value indicates decreased level of the metabolite. (Percentage of the control 
was taken as 0%) (n=3 ± SD; p≤0.05). ** Denotes a significant difference (p ≤0.01). 
 
 Metabolites such as pyruvate, isocitrate, αKG and succinate were found to be 
significantly higher in differentiated cells, all analyzed to be significant. Lactate level, 
however, was found to be significantly reduced in differentiated cells compared to the 
control counterpart.  Day 3 and day 7 metabolite profiles demonstrated similar results as 
the level of pyruvate, αKG and succinate was found to be increased over 100 fold. Again, 
the lactate presence was found to be reduced in day 3 and day 7 of DMSO-differentiated 
cells, thus suggesting the prominence of the TCA cycle in the differentiated cells. 
 To assess the level of energy metabolism, CFE of undifferentiated and 
differentiated cells were incubated in a) acetoacetate, a ketone body that can be 
metabolised into acetyl-CoA to produce energy via the TCA cycle, and b) succinate, an 
intermediate substrate of TCA cycle. The reaction was allowed to run for 1 hour. 
Consumption of these metabolites was then studied with HPLC. Additional experiments 
were performed with KCN in order to confirm that the consumption of acetoacetate and 
succinate was indeed a result of the TCA cycle and oxidative phosphorylation (Figure 
4.3a,b). CFE of differentiated cells were found to consume significantly higher 
acetoacetate and succinate.  
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a) 
 
b) 
 
Figure 4. 3. Acetoacetate and succinate consumption of CFE. 
a) DMSO-differentiated cells were shown to consume higher levels of acetoacetate. KCN 
treatment demonstrated that the consumption was indeed through metabolic enzymes. b) 
HPLC analysis of CFE succinate consumption. Undifferentiated (control) and 
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differentiated (DMSO) CFE both demonstrated consumption of succinate. However, 
DMSO-treated cells demonstrated trend of higher succinate consumption compared to the 
control.  KCN treatment demonstrated that the succinate consumption was through 
metabolic activity. (n=3 ± SD; p≤0.05). * Denotes a significant difference (p ≤0.05) 
 
As the metabolites in the oxidative phosphorylation were disparate between the 
undifferentiated and differentiated cells, it was important to assess the key enzymes 
involved in central energy metabolism. 
 
4.2.2. Assessing enzymatic activities by BN-PAGE 
To examine the enzymatic activity, cytosolic and mitochondrial proteins were 
isolated and prepared for BN-PAGE. The enzymes were probed using activity assay 
(recipes provided in Table 3.3) (Table 4.1).  
 
Table 4. 1. In-gel activity of central metabolic network in cytoplasm and mitochondria. 
Control and DMSO-differentiated cells were grown and isolated at day 3 and day 7. The 
samples were prepared for BN-PAGE and in-gel activity assay was performed to monitor 
the difference in the enzymatic activities (↑=high in-gel activity, ↓= low in-gel activity, - 
= no discernible bands) 
 
Enzymes Day 3 (differentiated) Day 7 (differentiated) 
HK ↓ ↑ 
GPI ↓ ↑ 
PK ↓ ↑ 
Complex I ↓ ↑ 
Complex II ↓ ↑ 
Complex IV ↓ ↑ 
Succinyl CoA transferase ↓ ↑ 
Malate dehydrogenase ↑ ↓ 
G6PDH - - 
ICDH-NAD
+
 - - 
KGDH - - 
Malic enzyme - - 
LDH (Cyt. & Mito.) - - 
GAPDH - - 
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Alanine transaminase - - 
Aspartate transaminase - - 
 
 Enzymes in glycolysis (HK,GPI and PK) and oxidative phosphorylation (Complex 
I, Complex II and Complex IV) were all found to have increased activity in day 7 
compared to day 3 (Figure 4.4). Undifferentiated cells, however, consisted of very faint or 
no discernible bands. This may be due to the limits of BN-PAGE and not the presence of 
the enzyme. More sensitive techniques such as immunochemistry could reveal the 
expression. However, as the study mainly focuses on functional proteomics and 
metabolomics, no further experiments were performed to identify the expression of 
undetected enzymes. The enzyme activity was confirmed by excising the site of activity 
band and confirming with HPLC (Figure 4.5). 
 
a) 
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b) 
 
Figure 4. 4. BN-PAGE in-gel activity assay 
a) Activity assays were performed for various metabolic enzymes. Image J software was 
used to quantify the band density. A representative electrogram is depicted. All the 
enzymes were assayed with control counter parts as shown in GPI and MDH in order to 
validate the differences are caused by differentiation. b) Equal loading was assured by 
staining total proteins with Coomassie R-250. Representative electrograms are depicted. 
Note: Complex IV enzymatic activity is depicted in the illustration. 
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Figure 4. 5. A representative HPLC analysis performed on BN-PAGE activity assays. 
The site of activity on the gel was excised and placed in reaction mixture containing 
appropriate substrates. The gel was incubated for 30 minutes. The consumption of 
substrates and formation of products were analyzed. For instance, PK activity band was 
excised and placed in reaction mixture containing PEP and ADP. The gel was incubated 
for 30 minutes and the sample was injected into HPLC. The level of PEP and ADP was 
found to decrease as the enzyme consumed these substrates. Pyruvate and ATP were 
found to increase after 30 minutes, confirming that the enzyme on BN-PAGE was indeed 
PK. (n=3 ± SD; p≤0.05). 
 
4.2.3 Mitochondrial ATP production 
The  enzymes involved in ETC and TCA cycle intermediate metabolites were 
observed to be  increased in differentiated cells, suggesting an increased mitochondrial 
activity. Thus, it was important to assess and compare the ability of mitochondria to 
produce ATP in undifferentiated and differentiated cells. In order to examine the ability 
of mitochondria to generate ATP, the mitochondrial subcellular fraction of control and 
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DMSO-treated cells were isolated and incubated in 2 mM succinate or malate, TCA 
intermediates, and 0.5 mM ADP for 1 hour. HPLC analysis suggests that the presence of 
TCA cycle substrates and ADP, in the differentiated mitochondrial fraction produced 
higher levels of ATP (Figure 4.6). 
 
 
 
Figure 4. 6. ATP production in the mitochondria. 
Mitochondrial fraction from control and DMSO-treated cells were incubated with 2 mM 
succinate or malate along with 0.5 mM ADP for one hour at 37 ˚C. Samples were boiled 
to stop the reactions and the amount of ATP was analyzed via HPLC analysis. (n=3 ± SD; 
p≤ 0.05) * Denotes a significant difference (p ≤0.05). ** Denotes a very significant 
difference between the control and DMSO-subjected cells (p ≤ 0.001). 
 
 As the activity of mitochondrial enzymes were elevated and mitochondrial 
fraction demonstrated higher ATP producing ability in differentiated cells, it was 
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imperative to investigate the changes in mitochondrial activity and biogenesis during 
differentiation of these stem cells.  
 
4.2.4 Mitochondrial activity and biogenesis 
Rhodamine dye is a well-known chemical agent that can be utilized to monitor 
membrane potential of mitochondria within the cell [172,173]. EBs were isolated and 
disaggregated at day 4. Cells were then seeded on coverslips and allowed to adhere 
overnight. Rhodamine dye was applied as described previously in the methods section. 
The results from microscopy showed that DMSO-exposed cells consisted of higher 
mitochondrial activity, even at an earlier stage of differentiation (Figure 4.7). 
 
96 
 
 
 
Figure 4. 7. Visualization of mitochondrial membrane potential via Rhodamine B dye. 
Control and DMSO-treated EBs were disaggregated and seeded on coverslips. The cells 
were subjected to Hoechst, for nuclear identification, followed by rhodamine to visualize 
mitochondrial membrane potential. The cells were imaged on a deconvolution fluorescent 
microscope. (Scale bar = 10 μm). A representative micrograph is depicted in the figure. 
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 To examine the difference in mitochondrial biogenesis between undifferentiated 
and differentiated cells, immunofluorescent microscopy was performed to visualize the 
level of VDAC, a mitochondrial marker, and PGC-1α, a master regulator of 
mitochondrial biogenesis. The results indicate elevated expression of VDAC and PGC-1α 
in DMSO-induced differentiated cells (Figure 4.8 and Figure 4.9). 
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Figure 4. 8. VDAC expression in undifferentiated and differentiated cells. 
In-cell western was performed using Hoescht as a counter stain to visualize the nucleus 
(blue), rhodamine B dye (red) and anti-VDAC primary antibody conjugated with FITC-
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tagged secondary antibody (green). A deconvolution microscope was used to visualize the 
cells after treatment. (Scale bar = 20 μm). A representative micrograph is depicted in the 
figure. 
 
 
 
Figure 4. 9. PGC-1α expression in undifferentiated and differentiated cells. 
In-cell western was performed using Hoescht as a counter stain to visualize the nucleus 
(blue) and anti-PGC-1α primary antibody conjugated with FITC-tagged secondary 
antibody (yellow). A deconvolution microscope was used to visualize the cells after 
treatment. (Scale bar = 20 μm). A representative micrograph is depicted in the figure. 
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 Overall, these results suggest that mitochondrial activity and mitochondrial 
biogenesis undergo drastic changes during differentiation, even at an earlier stage of 
differentiation.  
 
4.3 Nuclear metabolism 
Previous work from our laboratory has uncovered an intricate connection between 
metabolism and epigenetics in HepG2 cells [80]. Nuclear lactate dehydrogenase was 
found to participate in the regulation of histone deacetylation by modulating NAD
+
 
concentration. These findings prompted us to investigate the potential role of nuclear 
metabolism in stem cell differentiation. 
 
4.3.1 Nuclear purity 
Prior to starting nuclear experiments, it was pivotal to assess nuclear purity in 
subcellular fractionations. Cells were separated into nuclear and cytosolic fractions 
through differential centrifugation as described in the methods section. Both fractions 
were probed for actin to examine potential cytosolic contamination in the nuclear fraction 
(Figure 4.9). Absence of actin expression in nuclear fraction confirmed the purity of 
nuclear fractions obtained during differential centrifugation. 
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Figure 4. 10. Western blot analysis of nuclear purity. 
Control and DMSO-treated cells were isolated and the cytosolic and nuclei were 
differentiated. Both fractions were tested for presence of actin to examine the purity of 
nuclear fraction. 
 
4.3.2 Preliminary work 
HPLC analysis was performed to examine the differences in the concentrations of 
key metabolites in the nucleus. Nuclear contents indicated that there were marked 
differences in metabolite levels in undifferentiated and differentiated cells. Differentiating 
cells consisted of generally higher metabolite level with the exception of acetate (Figure 
4.10). 
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Figure 4. 11. Nuclear metabolic profile in control and DMSO-treated cells. 
Nuclei were isolated from undifferentiated and differentiated cells and metabolic profile 
was obtained from HPLC analysis. (n=3 ± SD; p≤ 0.05). *Denotes a significant difference 
(p ≤ 0.05). **Denotes a very significant difference (p ≤ 0.01). 
 
The presence of various metabolites and disparate metabolite levels indicates 
possible localization of metabolic enzymes in the nucleus. To determine this, nuclear 
subcellular fractions were isolated and subjected to BN-PAGE. Several metabolic 
enzymes were detected (Table 4.2). The enzymes LDH, ACL, PK and ICDH were 
prominent in the nucleus. The localization and function of nuclear ACL has been previous 
reported [73]. Although LDH has also been previously discovered in the nucleus, the role 
of this enzyme in the nucleus remained elusive to date.  
 
Table 4. 2. In-gel activity of metabolic enzymes in the nucleus 
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The isolated nuclei from DMSO-differentiated cells (day 3 and day 7) were subjected to 
BN-PAGE. Enzymes from central metabolism were probed using activity assay (previous 
described) to examine the presence of these enzymes. (↑=high in-gel activity, ↓= low in-
gel activity, - = no discernible bands). 
 
Enzyme Day 3 Day7 
LDH ↑ ↓ 
ACL ↓ ↑ 
PK ↓ ↑ 
ICDH ↑ ↓ 
G6PDH - - 
GPI - - 
MDH - - 
ME - - 
 
 No discernible band of indicative of the other enzymes such as G6PDH, GPI, 
MDH and ME, may be due to the limits of BN-PAGE and not the absence of the enzymes. 
More sensitive techniques could be used to further analyze the presence of these enzymes 
in the nucleus. As the role of nuclear LDH has been previously identified in a HepG2 cell 
line, particular attention was given to delineate possible roles of nuclear LDH in the 
differentiating stem cells. 
 
4.3.3 Nuclear lactate dehydrogenase 
To determine whether nuclear LDH plays a role in differentiation, nuclear 
fractions from undifferentiated and differentiated cells were subjected to in-gel activity 
assays. To confirm whether the bands were LDH, the activity bands were excised and 
placed in a reaction buffer containing 2 mM lactate and 0.5 mM NAD
+
. The reaction 
mixture was incubated for 30 minutes and lactate consumption was monitored (Figure 
4.12). 
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Figure 4. 12. LDH in-gel activity assay and HPLC confirmation. 
Nuclear proteins (60 μg) was loaded into a blue native gel and subjected to 
electrophoresis. An activity assay was performed for LDH. Image J software was used to 
quantify the band density. The band from the control LDH was then excised and 
incubated in a solution of 2 mM lactate and 0.5 mM NAD
+
 at 37˚C for 30 minutes. 
Lactate consumption was monitored by HPLC.  Note: Control activity bands were used as 
no significant LDH activity was observed from DMSO-treated cells. A representative 
electrogram and chromatogram is depicted. (n=3 ± SD; p≤0.05). *Denote a significant 
difference (p ≤0.01). ** Denotes a very significant difference (p ≤0.001) 
 
4.3.4 Expression of LDH in the nucleus 
LDH expression was measured by immunofluorescent techniques. Western blot, 
immunofluorescent microscopy and 96-well plate in-cell western were used to examine 
the overall LDH expression and nuclear LDH expression. As LDH-5 is known to localize 
in the mitochondria, anti-LDH-5 was used in immunofluorescent microscopy. The results 
from immunofluorescent microscopy and 96-well plate in-cell western showed that the 
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expression of LDH was higher in undifferentiated cells (Figure 4.13a, c). An enlarged 
image of microscopy represents localization of LDH-5 in nucleus (Figure 4.12b). Western 
blot analysis of nuclear fraction with polyclonal anti-LDH demonstrated higher 
expression of LDH in nucleus (Figure 4.13d). 
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Figure 4. 13. Expression of LDH and proof of LDH nuclear localization. 
a) EBs from control and DMSO-treated cells were disaggregated and seeded on 
coverslips. Immunofluorescent microscopy was performed with primary anti-LDH-5 and 
a secondary antibody conjugated to the FITC. Hoeschst was used to visualize the nucleus. 
The cells were visualized on deconvolution fluorescent microscope. (Scale bar = 10μm). 
b) Enlarged image of anti-LDH-5 immunofluorescent microscopy. White arrows indicate 
localization of LDH in nucleus. c) EBs were disaggregated and equal number of cells 
were seeded on 96-well plate. Immunostaining was performed with a primary anti-LDH 
and a secondary antibody conjugated to the FITC. (n=3 ± SD; p≤0.05). d) Nuclear 
fraction was isolated from undifferentiated and differentiated cells. Western blot was 
performed to examine the expression of LDH in the nucleus. Image J was used to 
quantify the band density. Representative results are depicted. 
 
4.3.5 Nuclear lactate dehydrogenase, NAD+ and sirtuins. 
As nuclear LDH has been found to regulate the level of NAD
+
 in HepG2 cells, the 
possibility that a similar role was being performed by the enzyme in the P19 embryonal 
carcinoma cells was assessed. First, the level of NAD
+
 consumption in the nucleus was 
examined. Nuclear fractions of undifferentiated and differentiated cells were incubated 
with 2 mM NAD
+
 at 37˚C for 1 hour and analyzed by HPLC. The results demonstrated 
that control nuclei consumed NAD
+ 
at an elevated rate (Figure 4.14). 
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Figure 4. 14. NAD
+
 utilization in the nucleus. 
Whole nuclei isolated from undifferentiated and differentiated cells were incubated in a 
reaction mixture containing 2 mM NAD
+
 for one hour at 37 ˚C. The level of NAD+ 
consumption was measured and compared to time zero. n=3 ± SD; p≤ 0.05. * Denotes a 
significant difference (p ≤ 0.05). 
 
 As NAD
+
 participates in the regulation of sirtuin histone deacetylases, higher 
consumption of NAD
+
 in control cells suggests increased histone deacetylation (lower 
acetylated histones). To examine the histone acetylation, histones were extracted and 
hydrolyzed from undifferentiated and differentiated cells. The results revealed that the 
level of histone acetylation was indeed significantly lower in the control cells (Figure 
4.15). 
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Figure 4. 15. Histone acetylation of nuclear extracts. 
Nuclei from undifferentiated and differentiated cells were isolated. Histones were purified 
and hydrolyzed. The level of acetate from histones were then measured with HPLC at a 
flow rate of 0.2 mL/minute for 40 minutes. n=3 ± SD; p≤ 0.05. ** Denotes a very 
significant difference (p ≤ 0.001). 
 
 To further support these results, the level of histone acetylation in the intact cell 
was examined with immunofluorescent microscopy and 96-well plate in-cell western blot. 
Indeed, the undifferentiated cells consisted of overall lower amounts of acetylated lysine 
residues as depicted in Figure 4.16a,b. 
 
a) 
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b)  
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Figure 4. 16. Immunostaining of acetylated lysine residues in undifferentiated and 
differentiated cells. 
 
a) Control and DMSO-treated EBs were disaggregated and grown on coverslips. 
Immunofluorescent microscopy was done using Hoescht to visualize the nucleus (blue) 
and an anti-acetylated lysine primary antibody. A FITC-tagged secondary antibody was 
used to visualize the images on a deconvolution microscope. (Scale bar = 10 μm). A 
representative micrograph is shown. b) EBs were disaggregated and equal number of cells 
were seeded on 96-well plate flask. Immunostaining was performed with a primary anti-
acetylated lysine and a secondary antibody conjugated to the FITC. Image J was used to 
quantify the fluorescent density.  
 
 Sirtuins (SIRT1) are known to be responsible for histone deacetylation [49]. To 
examine whether the difference in histone acetylation was indeed a result of disparate 
nuclear LDH activity or just a result of an increase in sirtuin expression, SIRT1 
expression was investigated. SIRT1 was chosen as this sirtuin is the predominantly 
localized in nucleus [174,175]. Utilizing anti-SIRT1 primary antibody and FITC-tagged 
secondary antibody, SIRT1 expression was visualized via immunofluorescent microscopy 
and 96-well plate in-cell western blot. The results showed that the expression of SIRT1 
between undifferentiated and differentiated was relatively similar (Figure 4.17a,b). 
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a) 
 
b) 
 
 
Figure 4. 17. SIRT1 expression in undifferentiated and differentiated cells. 
a) EBs were disaggregated and seeded on coverslips. The cells were grown overnight and 
subjected to immunofluorescent microscopy. The nuclei were visualized by Hoescht and 
SIRT1 expression was examined by anti-SIRT1 primary antibody. A deconvolution 
microscope was used to visualize the cells after staining (scale bar = 20 μm). b) EBs were 
disaggregated and equal number of cells were seeded on 96-well plate flask. 
Immunostaining was performed with a primary anti-SIRT1 and a secondary antibody 
conjugated to the FITC. Image J was used to quantify the band density. Representative 
results are depicted. 
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 These data suggest a link between LDH, NAD
+
 and sirtuins. Nuclear LDH may 
contribute to the modulation of NAD
+
 concentration in the nucleus, an event that can 
trigger the activity of sirtuin. Hence, an increase in deacetylation of histones would be 
observed during elevated nuclear LDH activity. Next, siRNA inhibition experiments were 
performed to solidify the evidences indicating the role of nuclear LDH in deacetylation of 
histones. 
 
4.3.6 siRNA LDH inhibition 
Double-stranded RNA (dsRNA) was used in attempt to inhibit LDH expression in 
P19 cells. LDHA specific small interfering RNA (siRNA) was chosen as LDH-5 is 
known to reside in the nucleus and it is comprised only of LDHA subunit. If indeed 
increased LDH activity in the nucleus promotes histone deacetylation, inhibition of LDH 
expression should result in elevated level of acetylation on histones (decreased histone 
deacetylation). The inhibition of LDHA via siRNA indeed revealed such a possibility 
(Figure 4.18). HPLC analyses indicated that histone acetylation increased by 
approximately 1.5-fold in the LDHA siRNA-treated cells compared to P19 non-treated 
and negative control siRNA subjected cells.  
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Figure 4. 18. HPLC analysis of histone acetylation under LDH siRNA inhibition. 
P19 embryonal carcinoma cells were grown to 70% confluency and transfected with P19 
non-treated, control siRNA and LDHA siRNA. Histones were isolated and the level of 
acetylation was analyzed by HPLC. (n=3 ± SD; p≤ 0.05) ** Denotes a very significant 
difference (p ≤ 0.001). 
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 The LDHA inhibited cells were also subjected to the differentiation protocol and 
histones were extracted. Differentiation was performed in liquid suspension promoting 
EB formation in the presence and absence of DMSO, respectively. The EBs were isolated 
at day 2 in order to conserve the effect of siRNA inhibition. Histones were extracted and 
hydrolyzed to monitor the level of acetylation. Acetylation of histones upon 
differentiation was again increased upon LDHA inhibition (Figure 4.19a). Differences in 
the level of histone acetylation among the samples were also examined. The results were 
expressed as percentage of control. It was shown that the LDHA siRNA inhibited cells 
exhibit reduced percent difference between DMSO-treated and control cells, indicating 
that the acetylation of histones were significantly increased in undifferentiated cells 
(Figure 4.19b).  
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a) 
 
 
b) 
 
Figure 4. 19. HPLC analysis of histone acetylation under LDH siRNA inhibition during 
differentiation. 
 
a) P19 embryonal carcinoma cells were grown to 70% confluency and transfected with 
control siRNA and LDHA siRNA. The cells were differentiated with 1% DMSO for 2 
days prior to isolation (Control cells was grown without DMSO). Histones were isolated 
and the level of acetylation was analyzed by HPLC. b) Percent differentiation of histone 
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acetylation between differentiated and undifferentiated cells.  (n=3 ± SD; p≤ 0.05) 
*Denotes a significant difference (p ≤ 0.05). **Denotes a very significant difference (p ≤ 
0.001). Note: in the presence of LDHA siRNA, the difference of histone acetylation was 
decreased. 
 
5. Discussion 
5.1 Differentiation and metabolism in stem cells 
The data suggest that DMSO treatment of the P19 embryonal carcinoma cells was 
effective as a morphogen, since the level of OCT4 expression, a marker of pluripotency, 
was sharply diminished. Hence, these DMSO-subjected cells were indeed differentiating 
(Figure 4.1). Since the discovery of stem cells and their potential for clinical applications, 
numerous studies are being undertaken in effort to fully delineate the molecular 
mechanism of pluripotency and differentiation. Global gene expression patterns and 
monitoring epigenetic regulation of ESCs have uncovered important genes involved in 
maintaining stemness and promoting differentiation [176,177]. Although these 
advancements have provided pivotal information about stem cells, the molecular 
frameworks governing these cells are yet to be fully understood. 
Metabolism is an ideal candidate for investigation as it is considered the end 
products of various gene expressions and is often intimately connected to the regulation 
of gene expressions. For instance, activity of NADP
+
-ICDH was shown to be up-
regulated and produce the ketoacid αKG under ROS stress, which serves to neutralize 
ROS via non-enzymatic decarboxylation producing CO2 and the organic acid, succinate. 
Accumulation of succinate can then stimulate hypoxia inducible factor-1α (HIF-1α) 
translocation by inhibiting prolyl hydroxylase 2 (PHD2). This nuclear translocation of 
HIF-1α then promotes hypoxic gene programs which encourage cell survival, glucose 
utilization, substrate level phosphorylation and glycolysis [178]. Metabolic enzymes are 
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also shown to participate in gene expression. GAPDH was found to serve as a co-
activator to regulate the expression of histone H2B. The interaction, however, between 
GAPDH and DNA is suggested to be indirect [179]. However, studies identifying the 
connection between metabolism and stem cell differentiation are only beginning to 
emerge.  
In the present work, DMSO-induced differentiation leads to the accumulation of 
elevated levels of TCA cycle intermediates and oxidative metabolism-related metabolites 
such as succinate, αKG, isocitrate and pyruvate (Figure 4.2a). Similar observations were 
evident at day 3 and day 7 stage of differentiation, thus suggesting drastic changes in 
metabolism (Figure 4.2b). Metabolic fluctuations in P19 cells and other types of stem 
cells have been indirectly shown [152,157,180]. These studies all demonstrate metabolic 
changes are necessary for the proper differentiation of stem cells. However, the primary 
focus on metabolic changes has been at the gene expression or protein expression levels. 
The activities of enzymes involved in this process has yet to be demonstrated, a 
shortcoming this work is attempting to rectify. 
 
5.1.1 Mitochondrial metabolism 
As mitochondria are responsible for energy metabolism and various other 
essential functions in cellular systems, it is becoming apparent that this organelle also 
plays an essential role in stemness and the differentiation of stem cells. Particular focus 
was directed towards the investigation of the changes in mitochondrial ATP metabolism 
during the differentiation of P19 embryonal carcinoma cells under DMSO treatment. 
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5.1.1.1 Up-regulation of oxidative metabolism in differentiated cells 
To confirm if indeed disparate ATP-generating network were operative in 
undifferentiated and differentiated cells, the consumption of acetoacetate and succinate in 
these cells was monitored. Acetoacetate is a well-known energy source that is converted 
into acetyl-CoA, a metabolite that drives TCA cycle and eventually promotes production 
of ATP via oxidative phosphorylation. Succinate is a TCA cycle intermediate metabolite 
that can also partake in the oxidative phosphorylation. Thus, the cell with higher 
oxidative energy metabolism will consume these metabolites at an increased rate. This 
was indeed a case for DMSO-treated P19 cells as the acetoacetate and succinate were 
more readily consumed in the differentiated cells compared to undifferentiated cells 
(Figure 4.3). It was important to examine the metabolic enzymes involved in energy 
metabolism in these cells. 
Various enzymes were subjected to BN-PAGE analysis for their enzymatic 
activities. Indeed cytosolic enzymes, such as HK, GPI and PK, demonstrated increased 
activities as the cells continue to mature post-differentiation. Mitochondrial enzymes such 
as Complex I, Complex II and Complex IV also exhibited enhanced activities (Table 4.1; 
Figure 4.4a). Interestingly, glycolytic enzymes in DMSO-treated cells demonstrated 
increased activity despite energy demands were being met by enhanced oxidative 
phosphorylation. However, the differentiated cells consisted of reduced amount of lactate 
while pyruvate level was increased (Figure 4.2a,b). Thus, the enzymatic activities and 
HPLC analyses suggest that the glycolytic pathway is providing pyruvate to fuel the TCA 
cycle and there are less substrate level phosphorylation occurring in the cell. These results 
indeed corroborate with other studies indicating reduced level of substrate level 
phosphorylation observed by limited lactate production in differentiated cells [157,181] 
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(Figure 5). However, this is the first demonstration of increased activities of glycolysis 
enzymes supplying pyruvate to enhance production of energy in the differentiated cells. 
The scheme in figure 5.1 depicts the metabolic pathway leading to enhanced oxidative 
ATP production in differentiating cells. 
 
 
Figure 5. 1. Metabolic reconfiguration resulting in increased ATP production in DMSO-
treated P19 cells. 
 
The results of enzymatic activity assay suggest differentiation induces elevated central 
energy metabolism. Glycolysis is shown to be up-regulated to fuel pyruvate for TCA 
cycle. ETC enzyme activities were also up-regulated as a result of differentiation. 
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5.1.1.2 Differentiation promotes increased ATP production 
The up-regulation of enzymes in the electron transport chain and the higher TCA 
cycle metabolites are a clear indication of elevated oxidative phosphorylation, which 
occurs in mitochondria. Therefore, our next step was to examine the ability of 
mitochondria to generate ATP. The results indeed showed that DMSO-treated cells 
produced significantly higher level of ATP when the mitochondrial fractions were 
exposed substrates like succinate and malate with ADP (Figure 4.5). As this experiment 
was performed only on mitochondrial fraction, it was evident that this organelle is 
undergoing dramatic changes during differentiation. Thus, we sought to confirm if indeed 
there was a shift towards increased mitochondrial biogenesis in the differentiating cells. 
 
5.1.1.3 Mitochondrial activity and biogenesis is promoted during differentiation 
HPLC analyses, enzymatic activities and ATP production all point to elevated 
mitochondrial activity in differentiated cells. To confirm this hypothesis, microscopy 
aided in the visualization of mitochondrial activity. Rhodamine dyes are recognized 
mitochondrial detectors as they help in the identification of membrane potential, a finger 
print of mitochondrial activity [172,182]. Enhanced mitochondrial activity will promote 
higher membrane potential across the mitochondrial membrane, in turn promoting greater 
ATP production via ETC. The results confirmed this postulation as rhodamine fluorescent 
was clearly higher in the differentiated cells (Figure 4.7).  
Next, the level of mitochondrial biogenesis was examined. The increase in 
mitochondrial activity may be reflective of the presence of increased mitochondria in the 
cell. Although the change in mitochondrial biogenesis during differentiation has been 
shown in other cells lines, this phenomenon has yet to be proven in the P19 cells. 
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[157,183,184,185]. Thus, we investigated whether the alteration in metabolism of 
DMSO-differentiated P19 cells were also caused by up-regulated presence of 
mitochondria. First, VDAC expression was visualized by microscopy. VDACs, localized 
on the outer mitochondrial membrane often serve as mitochondrial marker as this protein 
is expressed specifically on mitochondria. Thus, DMSO-treated cells should consist of 
higher level of VDAC. The microscopy was performed with rhodamine B dye and VDAC 
to demonstrate overlap of mitochondrial activity and biogenesis. The result revealed that 
there were indeed increased amount of mitochondria present in the differentiated cells. 
Also the rhodamine B dye clearly overlaps the VDAC fluorescent, indicating rhodamine 
B dye was detecting mitochondrial membrane potential (Figure 4.8).  
To provide further confirmation of increased mitochondrial biogenesis, PGC-1α 
expression was monitored. PGC-1α is a master regulator of mitochondrial biogenesis and 
the expression should be elevated in differentiated cells. The expression of PGC-1α has 
been shown in cells such as brown fat, mesoderm and neural differentiation 
[186,187,188]. To our knowledge, this the first study demonstrating the expression of 
PGC-1α in DMSO-treated P19 cells [189]. The in-cell western of PGC-1α confirmed our 
hypothesis of increased mitochondrial biogenesis as the expression of this transcription 
factor was higher in the differentiated cells (Figure 4.9) (Figure 5.2). Hence, DMSO 
promotes increased mitochondrial biogenesis, a feature that results in the loss of the 
stemness of P19 cells. 
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Figure 5. 2. Changing mitochondrial metabolism during stem cell differentiation 
The result of mitochondrial study demonstrates drastic change in its energy metabolism. 
Several key glycolytic enzymes and ETC enzymes were up-regulated in differentiated 
cells. Monitoring the membrane potential and expression of VDAC and PGC-1α showed 
that mitochondrial activity and biogenesis were up-regulated in DMSO-treated cells. 
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5.1.2 Nuclear metabolism 
Numerous studies have led to the discovery of a variety of biomolecules localized 
in the nucleus and their potential roles in epigenetic regulations [190]. However, the 
origin and interactions of these nuclear metabolites and the mechanism of action remain 
elusive to date. Recent work has demonstrated possible link between nuclear metabolic 
enzymes and histone modification. ACL has been shown to metabolize citrate in the 
nucleus into acetyl-CoA, a substrate required for HAT activity. HATs then acetylates 
histones, common epigenetic modifications found to up-regulate gene expressions of 
several glycolytic enzymes [73]. Also work done in our laboratory has unveiled the role 
of nuclear LDH in HepG2 cells. Nuclear LDH was found to regulate the level of NAD
+
, 
thus modulating SIRT1 activity and promoting histone deacetylation [80]. Despite these 
efforts, the function of nuclear metabolism in epigenetics is still not fully understood. 
Especially, there is a dearth of studies dealing with the potential impact of nuclear 
metabolism in stem cell differentiation. Thus, in this project, the potential role of nuclear 
LDH in P19 embryonal carcinoma cells was also examined. 
 
5.1.2.1 Nuclear lactate dehydrogenase is up-regulated in nucleus of undifferentiated 
stem cells. 
Metabolomic analyses revealed significant change in the metabolic profile of the 
nucleus during differentiation (Figure 4.11). Electrophoretic studies led to the discovery 
of several metabolic enzymes residing in the nucleus of P19 cells (Table 4.2). As shown, 
ACL and LDH were present in the nucleus of the cell. The nuclear association of PK and 
ICDH were demonstrated. Since LDH has been reported to play a critical role in the 
epigenetic of HepG2 cells, the involvement of this enzyme in the nucleus of P19 cells 
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were further investigated. Interestingly, the activity of ACL and LDH appeared to be 
reversed where ACL is more active in day 7 and LDH activity was higher during day 3 of 
differentiation. This prompted us to consider whether the nuclear LDH has a potential 
role in pluripotency or differentiation of stem cells. The result indicated that nuclear LDH 
in undifferentiated cells maintain increased activity (Figure 4.12). The control band was 
excised and incubated in a reaction mixture containing lactate and NAD
+
 to confirm that 
the enzyme is LDH (Figure 4.12). The LDH activity bands from DMSO-treated cells 
were barely discernible. This enzyme was confirmed by numerous techniques including 
HPLC, fluorescence microscopy, electrophoresis and siRNA inhibition. These clearly 
revealed the significance of LDH in the nucleus. Previous studies have identified LDH-5 
in the nucleus [77,78,79,80]. LDH-5, consisting of only LDHA subunit, preferentially 
oxidizes NADH in the presence of pyruvate to form lactate and NAD
+
. To confirm the 
presence of LDH-5 in the nucleus, anti-LDH-5 primary antibody was used to visualize the 
localization of LDH in the nucleus via immunofluorescent microscopy and western blot 
of nuclear fractions (Figure 4.13 a,b,d). Overall LDH expression in control and DMSO-
treated cells were also monitored via 96-well plate in-cell western (Figure 4.13 c). The 
expression and localization studies indeed did confirm the presence of LDH in the 
nucleus. 
 
5.1.2.2 Nuclear lactate dehydrogenase modulates level of nuclear NAD+ 
Much like the nuclear ACL providing acetyl-CoA for HATs to promote histone 
acetylation [73], LDH appears to provide NAD
+
 for sirtuins to promote histone 
deacetylation. It should be noted, however, nuclear NAD
+
 can regulate a variety of other 
proteins in the nucleus also [191], thus, indicating a pivotal role of NAD
+
 in the nucleus. 
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NAD
+
 consumption experiment demonstrated that the nuclear extracts from the 
undifferentiated cells consumed significantly more NAD
+
 than the nuclei from DMSO-
treated cells, an observation indirectly confirming the higher level of LDH in the control 
cells (Figure 4.14). Since the major NAD
+
 utilizing protein in the nucleus is sirtuin, 
attempts were made to identify the connection between the nuclear LDH and sirtuins. In 
particular, SIRT1 was studied as it is the best characterized, nuclear localized enzyme in 
this family and possesses HDAC activity [192]. 
The level of histone acetylation was examined as SIRT1 is known to deacetylate 
histones. HPLC analyses suggested that undifferentiated cells consisted of significantly 
less acetylated histones (Figure 4.15). In-cell western microscopy and 96-well plate in-
cell western blot images confirmed these observations as the acetylated lysine residues in 
control cells were lower compared to the DMSO-treated cells. (Figure 4.17 a,b). However, 
further experiments were needed to ensure that nuclear LDH is indeed influencing the 
activity of sirtuin to modulate histone deacetylation. The level of SIRT1 expression was 
examined and similar SIRT1 expression level in undifferentiated and differentiated cells 
was detected. Hence, elevated histone deacetylation in control cells was not due to SIRT1 
but rather to other factors like NAD
+
 (Figure 4.17 a,b). Hence, histone acetylation was 
found to correlate with nuclear LDH expression and activity, independent of SIRT1 
expression. As sirtuins are known to be regulated mainly by the NAD
+
:NADH ratio [68], 
these results suggest that nuclear LDH modulates the NAD
+
 concentration in the nucleus. 
This phenomenon appears to influence activity of sirtuins and histone deacetylation 
(Figure 5.3). 
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Figure 5. 3. LDH modulates nuclear NAD
+
 concentration in order to influence histone 
deacetylation. 
 
LDH expression and activity was found to be up-regulated in undifferentiated cells. Since 
SIRT1 expression remains similar in both control and DMSO-treated cells, LDH is 
suggested to provide NAD
+
 to modulate activity of SIRT1. Higher activity of sirtuin in 
undifferentiated cells due to increased availability of NAD
+
 induces histone deacetylation 
(lower acetyl content on histones). 
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5.1.2.3 Nuclear lactate dehydrogenase and histone deacetylation 
To further solidify the connection between nuclear LDH, sirtuins and histone 
acetylation, LDH inhibition experiments were performed. To inhibit the activity of 
nuclear LDH, LDHA siRNA was utilized. SiRNAs are commonly used inhibitory 
molecules that can temporarily inhibit protein expression. LDHA subunit inhibiting 
siRNA was chosen in order to produce selective inhibition of nuclear LDH. If the nuclear 
LDH is indeed a regulator of NAD
+
 concentration and histone deacetylation, inhibition of 
nuclear LDH should elevate the level of histone acetylation. Inhibition of LDH in P19 
cells did indeed revealed such a scenario. Comparison of levels of histone acetylation in 
P19 non-treated, negative control siRNA and LDHA siRNA treated cell showed that 
LDHA inhibited cells exhibit significant higher histone acetylation (Figure 4.18) (Figure 
5.4). The P19 cells (no treatment), control siRNA-treated and LDHA siRNA-treated cells 
were subjected to DMSO-induced differentiation (Figure 3.7). Since the effect of siRNA 
is temporary, cells were isolated at day 2 of differentiation to conserve the inhibition. 
Histones were again acetylated at increased level in LDH inhibited cultures (Figure 
4.19a). The differences in histone acetylation of control (non DMSO-treated) and DMSO-
treated cells were analyzed (Figure 4.19b). Upon LDHA siRNA inhibition, the control 
cells exhibited significantly higher level of acetylated histones compared to the control 
cells of P19 (no inhibition) and control siRNA-treated cells. Note the percentage 
difference in LDHA siRNA-treated cells was significantly reduced. Hence, the LDHA 
siRNA inhibition experiments suggest that LDH participates in modulating the level of 
histone deacetylation. In particular, higher LDH activity in undifferentiated cells indicates 
that the LDH could be involved in silencing gene expressions during self-renewal period 
of stem cells. Since SIRT1 has been linked to regulation of metabolic network in the cell, 
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it is possible that LDH participates in silencing certain metabolic pathways. Thus, further 
studies should be performed to identify the gene expressions influenced by the activity of 
nuclear LDH. 
 
 
Figure 5. 4. Link between LDH, sirtuin and histone deacetylation. 
If nuclear LDH was indeed a modulator of histone deacetylation, selective inhibition of 
LDH should promote lower histone deacetylase activity in the nucleus. Upon inhibition, 
the predicted metabolic shift indeed occurred. While uninhibited cells have lower level of 
acetylated histone residues, LDHA inhibited cells exhibit higher level of acetylated 
histone residues. 
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6. Conclusion 
The importance of metabolism in stem cell biology is only beginning to emerge. 
Here we provide convincing evidence for changes in mitochondrial and nuclear 
metabolism in differentiating stem cells. Mitochondrial activity and biogenesis were 
found to be enhanced under DMSO-induced differentiation of P19 cells. Activities of 
several key glycolytic and ETC enzymes and elevated mitochondrial ATP production 
suggest increased mitochondrial activity in the DMSO-treated cells. Additionally, 
mitochondrial biogenesis is partly responsible for the increased energy metabolism in 
differentiated cells. This was indeed confirmed by the higher level of expression of 
VDAC and PGC-1α in the differentiated cells. These changes indicate drastic variation in 
mitochondrial characteristics in stem cells and suggest a key role for mitochondria in 
differentiation, findings that add to our understanding of the link between this organelle 
and stemness. The occurrence of LDH in P19 cells is a seminal observation that injects a 
new twist to stem cell differentiation (Figure 5.5). 
Nuclear LDH was found to be over-expressed in pluripotent cells, but not in 
differentiated cells. The higher expression and activity of nuclear LDH were suggested to 
bridge a gap between the modulation of nuclear NAD
+
 concentration, SIRT1 and the level 
of histone deacetylation. The nuclear LDH appears to control NAD
+
 concentration in the 
nucleus via the oxidation of NADH into NAD
+
 with the subsequent conversion of 
pyruvate into lactate. NAD
+
 produced from this reaction is utilized by SIRT1 as a 
substrate to deacetylate histones. This metabolic regulation of histone deacetylation is 
indeed independent of SIRT1 expression, a discovery that bridges the gap between 
metabolism and epigenetics (Figure 5.5).  
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Figure 5. 5. Mitochondrial and nuclear metabolism undergoes drastic changes during 
differentiation. 
 
The results of this study suggest that differentiation induces increase energy metabolism 
via up-regulation of mitochondrial activity and biogenesis, in turn producing higher level 
of ATP for the cell. The nucleus also experiences changes. Lactate dehydrogenase in 
nucleus produces NAD
+
 in order to provide a key substrate for sirtuin-dependent 
epigenetic modification.  
 
In conclusion, this study suggests an intimate connection between mitochondrial 
and nuclear metabolism and stem cells. Further studies should be performed to uncover 
detailed molecular mechanism of mitochondrial biogenesis during differentiation. The 
nuclear LDH should also be further investigated in order to unveil whether gene 
expression correlates with LDH activity and histone deacetylation. Delineating these 
molecular mechanisms of metabolic alterations can lead to a better understanding of 
pluripotent cells and provide an additional tool to direct stem cells to a desired fate during 
differentiation. 
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